{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# **Dataset Analysis**\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## DrugBank"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "import xml.etree.ElementTree as ET\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import os\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def process_drugbank_xml(xml_file):\n",
    "    \"\"\"Extract drug descriptions from DrugBank XML\"\"\"\n",
    "    ns = {'db': 'http://www.drugbank.ca'}\n",
    "    tree = ET.parse(xml_file)\n",
    "    root = tree.getroot()\n",
    "    \n",
    "    descriptions = {}\n",
    "    for drug in root.findall('db:drug', ns):\n",
    "        # Get all possible names for the drug\n",
    "        names = []\n",
    "        \n",
    "        # Primary name\n",
    "        name = drug.find('db:name', ns)\n",
    "        if name is not None:\n",
    "            names.append(name.text.lower())\n",
    "        \n",
    "        # Synonyms\n",
    "        for synonym in drug.findall('.//db:synonym', ns):\n",
    "            names.append(synonym.text.lower())\n",
    "            \n",
    "        # Products\n",
    "        for product in drug.findall('.//db:product', ns):\n",
    "            name_element = product.find('.//db:name', ns)\n",
    "            if name_element is not None:\n",
    "                names.append(name_element.text.lower())\n",
    "        \n",
    "        # Get description\n",
    "        desc_elem = drug.find('db:description', ns)\n",
    "        if desc_elem is not None and desc_elem.text:\n",
    "            desc = desc_elem.text.strip()\n",
    "            # Add description for all names of this drug\n",
    "            for name in names:\n",
    "                descriptions[name] = desc\n",
    "    \n",
    "    return descriptions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 161137 drug descriptions\n"
     ]
    }
   ],
   "source": [
    "# Load drug descriptions from DrugBank\n",
    "descriptions = process_drugbank_xml('../full database.xml')\n",
    "print(f\"Loaded {len(descriptions)} drug descriptions\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 161137 entries, 0 to 161136\n",
      "Data columns (total 2 columns):\n",
      " #   Column       Non-Null Count   Dtype \n",
      "---  ------       --------------   ----- \n",
      " 0   Drug Name    161137 non-null  object\n",
      " 1   Description  161137 non-null  object\n",
      "dtypes: object(2)\n",
      "memory usage: 2.5+ MB\n",
      "None\n"
     ]
    }
   ],
   "source": [
    "drugbank_df = pd.DataFrame(list(descriptions.items()), columns=['Drug Name', 'Description'])\n",
    "\n",
    "# Display basic info\n",
    "print(drugbank_df.info())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>lepirudin</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[leu1, thr2]-63-desulfohirudin</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>desulfatohirudin</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>hirudin variant-1</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>lepirudin recombinant</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        Drug Name  \\\n",
       "0                       lepirudin   \n",
       "1  [leu1, thr2]-63-desulfohirudin   \n",
       "2                desulfatohirudin   \n",
       "3               hirudin variant-1   \n",
       "4           lepirudin recombinant   \n",
       "\n",
       "                                         Description  \n",
       "0  Lepirudin is a recombinant hirudin formed by 6...  \n",
       "1  Lepirudin is a recombinant hirudin formed by 6...  \n",
       "2  Lepirudin is a recombinant hirudin formed by 6...  \n",
       "3  Lepirudin is a recombinant hirudin formed by 6...  \n",
       "4  Lepirudin is a recombinant hirudin formed by 6...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugbank_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "lepirudin: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "[leu1, thr2]-63-desulfohirudin: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "desulfatohirudin: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "hirudin variant-1: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "lepirudin recombinant: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "r-hirudin: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "3.4.21.5: AZD-8165 is under investigation in clinical trial NCT01150812 (Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects).\n",
      "coagulation factor ii: AZD-8165 is under investigation in clinical trial NCT01150812 (Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects).\n",
      "refludan: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in _Hirudo medicinalis_ leeches.[L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on the tyrosine residue at position 63 and the substitution of leucine for isoleucine at position 1 (N-terminal end).[A246609] \n",
      "\n",
      "Lepirudin is used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT), an immune reaction associated with a high risk of thromboembolic complications.[A3, L41539] HIT is caused by the expression of immunoglobulin G (IgG) antibodies that bind to the complex formed by heparin and platelet factor 4. This activates endothelial cells and platelets and enhances the formation of thrombi.[A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574]\n",
      "cetuximab: Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor (EGF).[A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis.[A228083] EGFR has been implicated in various types of cancer, as it is often overexpressed in malignant cells [A227973] and EGFR overexpression has been linked to more advanced disease and poor prognosis.[A227963] EGFR is often mutated in certain types of cancer and serves as a driver of tumorigenesis.[A228083] _In vitro_, cetuximab was shown to mediate anti-tumour effects in numerous cancer cell lines and human tumour xenografts.[A227963]\n",
      "\n",
      "Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic colorectal cancer with a BRAF V600E mutation.[A227963,L39045] It has also been investigated in advanced colorectal cancer, EGFR-expressing non-small cell lung cancer (NSCLC), and unresectable squamous cell skin cancer.[L31418] Cetuximab is administered via intravenous infusion and is used as monotherapy or in combination with other chemotherapies, including platinum agents, radiation therapy, [leucovorin], [fluorouracil], and [irinotecan].[L30448]\n"
     ]
    }
   ],
   "source": [
    "# Print the first 10 for demonstration\n",
    "for name, desc in list(descriptions.items())[:10]:\n",
    "    print(f\"{name}: {desc}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total unique drugs: 161137\n"
     ]
    }
   ],
   "source": [
    "print(\"Total unique drugs:\", drugbank_df['Drug Name'].nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "       Description Length\n",
      "count       161137.000000\n",
      "mean            79.935266\n",
      "std             72.920953\n",
      "min              3.000000\n",
      "25%             37.000000\n",
      "50%             60.000000\n",
      "75%            104.000000\n",
      "max            887.000000\n"
     ]
    }
   ],
   "source": [
    "drugbank_df['Description Length'] = drugbank_df['Description'].apply(lambda x: len(x.split()))\n",
    "print(drugbank_df[['Drug Name', 'Description Length']].describe())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10, 5))\n",
    "sns.histplot(drugbank_df['Description Length'], bins=30, kde=True)\n",
    "plt.xlabel('Number of Words in Description')\n",
    "plt.ylabel('Frequency')\n",
    "plt.title('Distribution of Drug Description Lengths')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## DrugBank in relation with DDICorpus\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence</th>\n",
       "      <th>entity_1</th>\n",
       "      <th>entity_1_type</th>\n",
       "      <th>entity_2</th>\n",
       "      <th>entity_2_type</th>\n",
       "      <th>entity_3</th>\n",
       "      <th>entity_3_type</th>\n",
       "      <th>entity_4</th>\n",
       "      <th>entity_4_type</th>\n",
       "      <th>entity_5</th>\n",
       "      <th>...</th>\n",
       "      <th>entity_51</th>\n",
       "      <th>entity_51_type</th>\n",
       "      <th>entity_52</th>\n",
       "      <th>entity_52_type</th>\n",
       "      <th>entity_53</th>\n",
       "      <th>entity_53_type</th>\n",
       "      <th>entity_54</th>\n",
       "      <th>entity_54_type</th>\n",
       "      <th>entity_55</th>\n",
       "      <th>entity_55_type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>No drug, nutritional supplement, food or herb ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>No formal drug/drug interaction studies with P...</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>brand</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Cytochrome P-450 is not known to be involved i...</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>brand</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Plenaxis is highly bound to plasma proteins (9...</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>brand</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Laboratory Tests Response to Plenaxis should b...</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>brand</td>\n",
       "      <td>testosterone</td>\n",
       "      <td>drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6971</th>\n",
       "      <td>When taken concurrently with ethanol, a pharma...</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6972</th>\n",
       "      <td>In addition to this pharmacological interactio...</td>\n",
       "      <td>temazepam</td>\n",
       "      <td>drug</td>\n",
       "      <td>benzodiazepine</td>\n",
       "      <td>group</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6973</th>\n",
       "      <td>Optimal conditions, kinetics, equilibrium, and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6974</th>\n",
       "      <td>The results raise the possibility that the eth...</td>\n",
       "      <td>alcohol</td>\n",
       "      <td>drug</td>\n",
       "      <td>3-hydroxy-1,4-benzodiazepine</td>\n",
       "      <td>group</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6975</th>\n",
       "      <td>The acid-catalyzed ethanol-drug reaction is a ...</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>drug</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6976 rows × 111 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               sentence   entity_1  \\\n",
       "0     No drug, nutritional supplement, food or herb ...        NaN   \n",
       "1     No formal drug/drug interaction studies with P...   Plenaxis   \n",
       "2     Cytochrome P-450 is not known to be involved i...   Plenaxis   \n",
       "3     Plenaxis is highly bound to plasma proteins (9...   Plenaxis   \n",
       "4     Laboratory Tests Response to Plenaxis should b...   Plenaxis   \n",
       "...                                                 ...        ...   \n",
       "6971  When taken concurrently with ethanol, a pharma...    ethanol   \n",
       "6972  In addition to this pharmacological interactio...  temazepam   \n",
       "6973  Optimal conditions, kinetics, equilibrium, and...        NaN   \n",
       "6974  The results raise the possibility that the eth...    alcohol   \n",
       "6975  The acid-catalyzed ethanol-drug reaction is a ...    ethanol   \n",
       "\n",
       "     entity_1_type                      entity_2 entity_2_type entity_3  \\\n",
       "0              NaN                           NaN           NaN      NaN   \n",
       "1            brand                           NaN           NaN      NaN   \n",
       "2            brand                           NaN           NaN      NaN   \n",
       "3            brand                           NaN           NaN      NaN   \n",
       "4            brand                  testosterone          drug      NaN   \n",
       "...            ...                           ...           ...      ...   \n",
       "6971          drug                           NaN           NaN      NaN   \n",
       "6972          drug                benzodiazepine         group  ethanol   \n",
       "6973           NaN                           NaN           NaN      NaN   \n",
       "6974          drug  3-hydroxy-1,4-benzodiazepine         group      NaN   \n",
       "6975          drug                           NaN           NaN      NaN   \n",
       "\n",
       "     entity_3_type entity_4 entity_4_type entity_5  ... entity_51  \\\n",
       "0              NaN      NaN           NaN      NaN  ...       NaN   \n",
       "1              NaN      NaN           NaN      NaN  ...       NaN   \n",
       "2              NaN      NaN           NaN      NaN  ...       NaN   \n",
       "3              NaN      NaN           NaN      NaN  ...       NaN   \n",
       "4              NaN      NaN           NaN      NaN  ...       NaN   \n",
       "...            ...      ...           ...      ...  ...       ...   \n",
       "6971           NaN      NaN           NaN      NaN  ...       NaN   \n",
       "6972          drug      NaN           NaN      NaN  ...       NaN   \n",
       "6973           NaN      NaN           NaN      NaN  ...       NaN   \n",
       "6974           NaN      NaN           NaN      NaN  ...       NaN   \n",
       "6975           NaN      NaN           NaN      NaN  ...       NaN   \n",
       "\n",
       "     entity_51_type entity_52 entity_52_type entity_53 entity_53_type  \\\n",
       "0               NaN       NaN            NaN       NaN            NaN   \n",
       "1               NaN       NaN            NaN       NaN            NaN   \n",
       "2               NaN       NaN            NaN       NaN            NaN   \n",
       "3               NaN       NaN            NaN       NaN            NaN   \n",
       "4               NaN       NaN            NaN       NaN            NaN   \n",
       "...             ...       ...            ...       ...            ...   \n",
       "6971            NaN       NaN            NaN       NaN            NaN   \n",
       "6972            NaN       NaN            NaN       NaN            NaN   \n",
       "6973            NaN       NaN            NaN       NaN            NaN   \n",
       "6974            NaN       NaN            NaN       NaN            NaN   \n",
       "6975            NaN       NaN            NaN       NaN            NaN   \n",
       "\n",
       "     entity_54 entity_54_type entity_55 entity_55_type  \n",
       "0          NaN            NaN       NaN            NaN  \n",
       "1          NaN            NaN       NaN            NaN  \n",
       "2          NaN            NaN       NaN            NaN  \n",
       "3          NaN            NaN       NaN            NaN  \n",
       "4          NaN            NaN       NaN            NaN  \n",
       "...        ...            ...       ...            ...  \n",
       "6971       NaN            NaN       NaN            NaN  \n",
       "6972       NaN            NaN       NaN            NaN  \n",
       "6973       NaN            NaN       NaN            NaN  \n",
       "6974       NaN            NaN       NaN            NaN  \n",
       "6975       NaN            NaN       NaN            NaN  \n",
       "\n",
       "[6976 rows x 111 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def parse_ddi_corpus(xml_file):\n",
    "    tree = ET.parse(xml_file)\n",
    "    root = tree.getroot()\n",
    "\n",
    "    sentences = []\n",
    "    entities = []\n",
    "\n",
    "    for sentence in root.iter('sentence'):\n",
    "        sent_text = sentence.attrib['text']\n",
    "        sent_entities = []\n",
    "\n",
    "        for entity in sentence.iter('entity'):\n",
    "            ent_text = entity.attrib['text']\n",
    "            ent_type = entity.attrib['type']\n",
    "                        \n",
    "            sent_entities.append({\n",
    "                'text': ent_text,\n",
    "                'type': ent_type,\n",
    "            })\n",
    "\n",
    "        sentences.append(sent_text)\n",
    "        entities.append(sent_entities)\n",
    "\n",
    "    return sentences, entities\n",
    "\n",
    "def process_all_files_in_directory(directory):\n",
    "    all_results = []\n",
    "    # Iterate through all XML files in the directory\n",
    "    for filename in os.listdir(directory):\n",
    "        if filename.endswith(\".xml\"):\n",
    "            file_path = os.path.join(directory, filename)\n",
    "            \n",
    "            sentences, entities = parse_ddi_corpus(file_path)\n",
    "\n",
    "            all_results.append({'sentences': sentences, 'entities': entities})     \n",
    "    \n",
    "    return all_results\n",
    "\n",
    "processed_files_1 = process_all_files_in_directory(\"../DDICorpus/Train/DrugBank\")\n",
    "processed_files_2 = process_all_files_in_directory(\"../DDICorpus/Train/MedLine\")\n",
    "\n",
    "\n",
    "def convert_to_dataframe(processed_files):\n",
    "    data = []\n",
    "    \n",
    "    for entry in processed_files:\n",
    "        sentences = entry[\"sentences\"]\n",
    "        entities = entry[\"entities\"]\n",
    "        \n",
    "        for i, sentence in enumerate(sentences):\n",
    "            entity_list = entities[i] if i < len(entities) else []\n",
    "            \n",
    "            entity_texts = [e[\"text\"] for e in entity_list]\n",
    "            entity_types = [e[\"type\"] for e in entity_list]\n",
    "            \n",
    "            row = {\"sentence\": sentence}\n",
    "            \n",
    "            for idx, (text, type_) in enumerate(zip(entity_texts, entity_types)):\n",
    "                row[f\"entity_{idx+1}\"] = text\n",
    "                row[f\"entity_{idx+1}_type\"] = type_\n",
    "            \n",
    "            data.append(row)\n",
    "    \n",
    "    return pd.DataFrame(data)\n",
    "\n",
    "\n",
    "df_1 = convert_to_dataframe(processed_files_1)\n",
    "df_2 = convert_to_dataframe(processed_files_2)\n",
    "\n",
    "df_train = pd.concat([df_1, df_2], ignore_index=True)\n",
    "df_train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence</th>\n",
       "      <th>entity_column</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Description</th>\n",
       "      <th>Description Length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>No formal drug/drug interaction studies with P...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cytochrome P-450 is not known to be involved i...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Plenaxis is highly bound to plasma proteins (9...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Laboratory Tests Response to Plenaxis should b...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Serum transaminase levels should be obtained b...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>Plenaxis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            sentence entity_column Drug Name  \\\n",
       "0  No formal drug/drug interaction studies with P...      entity_1  Plenaxis   \n",
       "1  Cytochrome P-450 is not known to be involved i...      entity_1  Plenaxis   \n",
       "2  Plenaxis is highly bound to plasma proteins (9...      entity_1  Plenaxis   \n",
       "3  Laboratory Tests Response to Plenaxis should b...      entity_1  Plenaxis   \n",
       "4  Serum transaminase levels should be obtained b...      entity_1  Plenaxis   \n",
       "\n",
       "  Description  Description Length  \n",
       "0         NaN                 NaN  \n",
       "1         NaN                 NaN  \n",
       "2         NaN                 NaN  \n",
       "3         NaN                 NaN  \n",
       "4         NaN                 NaN  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Ensure Drug Name is lowercase for better matching\n",
    "drugbank_df['Drug Name'] = drugbank_df['Drug Name'].str.lower()\n",
    "\n",
    "# Reshape DDICorpus entity columns to a long format\n",
    "ddicorpus_entities = pd.melt(df_train, id_vars=['sentence'], \n",
    "                             value_vars=[col for col in df_train.columns if 'entity_' in col and '_type' not in col],\n",
    "                             var_name='entity_column', value_name='Drug Name').dropna()\n",
    "\n",
    "# Merge with DrugBank descriptions\n",
    "merged_df = ddicorpus_entities.merge(drugbank_df, on='Drug Name', how='left')\n",
    "\n",
    "# Display the merged DataFrame\n",
    "merged_df.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Drug Name\n",
      "digoxin          209\n",
      "warfarin         188\n",
      "phenytoin        167\n",
      "theophylline     134\n",
      "lithium          120\n",
      "ketoconazole     107\n",
      "alcohol           93\n",
      "cimetidine        93\n",
      "cyclosporine      84\n",
      "carbamazepine     83\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "print(merged_df['Drug Name'].value_counts().head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                  Drug Name\n",
      "0                  Plenaxis\n",
      "5                   ORENCIA\n",
      "6                       MTX\n",
      "8            TNF antagonist\n",
      "11                Abciximab\n",
      "...                     ...\n",
      "14744  somatostatin analogs\n",
      "14747              Viracept\n",
      "14755            Astramorph\n",
      "14759                Kadian\n",
      "14762             MS Contin\n",
      "\n",
      "[2100 rows x 1 columns]\n"
     ]
    }
   ],
   "source": [
    "missing_drugs = merged_df[merged_df['Description'].isna()]\n",
    "print(missing_drugs[['Drug Name']].drop_duplicates())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence</th>\n",
       "      <th>entity_column</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Description</th>\n",
       "      <th>Description Length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6568</th>\n",
       "      <td>plasma levels of several closely related tricy...</td>\n",
       "      <td>entity_2</td>\n",
       "      <td>methylphenidate</td>\n",
       "      <td>Methylphenidate is a central nervous system st...</td>\n",
       "      <td>677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14609</th>\n",
       "      <td>The most commonly occurring drug interactions ...</td>\n",
       "      <td>entity_15</td>\n",
       "      <td>methylphenidate</td>\n",
       "      <td>Methylphenidate is a central nervous system st...</td>\n",
       "      <td>677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14733</th>\n",
       "      <td>Drugs that reportedly may increase oral antico...</td>\n",
       "      <td>entity_29</td>\n",
       "      <td>methylphenidate</td>\n",
       "      <td>Methylphenidate is a central nervous system st...</td>\n",
       "      <td>677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>470</th>\n",
       "      <td>methylphenidate;</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>methylphenidate</td>\n",
       "      <td>Methylphenidate is a central nervous system st...</td>\n",
       "      <td>677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13224</th>\n",
       "      <td>Use lowest possible dose of atorvastatin with ...</td>\n",
       "      <td>entity_5</td>\n",
       "      <td>rosuvastatin</td>\n",
       "      <td>Rosuvastatin, also known as the brand name pro...</td>\n",
       "      <td>568</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13989</th>\n",
       "      <td>Interactions with Mixed Agonist/Antagonist Opi...</td>\n",
       "      <td>entity_7</td>\n",
       "      <td>buprenorphine</td>\n",
       "      <td>Buprenorphine is a weak partial mu-opioid rece...</td>\n",
       "      <td>567</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>904</th>\n",
       "      <td>Because CYP 3A4 inhibitors may increase plasma...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>buprenorphine</td>\n",
       "      <td>Buprenorphine is a weak partial mu-opioid rece...</td>\n",
       "      <td>567</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>906</th>\n",
       "      <td>Based on anecdotal reports, there may be an in...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>buprenorphine</td>\n",
       "      <td>Buprenorphine is a weak partial mu-opioid rece...</td>\n",
       "      <td>567</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>907</th>\n",
       "      <td>There have been a number of reports in the pos...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>buprenorphine</td>\n",
       "      <td>Buprenorphine is a weak partial mu-opioid rece...</td>\n",
       "      <td>567</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>908</th>\n",
       "      <td>In many of these cases, buprenorphine was misu...</td>\n",
       "      <td>entity_1</td>\n",
       "      <td>buprenorphine</td>\n",
       "      <td>Buprenorphine is a weak partial mu-opioid rece...</td>\n",
       "      <td>567</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                sentence entity_column  \\\n",
       "6568   plasma levels of several closely related tricy...      entity_2   \n",
       "14609  The most commonly occurring drug interactions ...     entity_15   \n",
       "14733  Drugs that reportedly may increase oral antico...     entity_29   \n",
       "470                                     methylphenidate;      entity_1   \n",
       "13224  Use lowest possible dose of atorvastatin with ...      entity_5   \n",
       "13989  Interactions with Mixed Agonist/Antagonist Opi...      entity_7   \n",
       "904    Because CYP 3A4 inhibitors may increase plasma...      entity_1   \n",
       "906    Based on anecdotal reports, there may be an in...      entity_1   \n",
       "907    There have been a number of reports in the pos...      entity_1   \n",
       "908    In many of these cases, buprenorphine was misu...      entity_1   \n",
       "\n",
       "             Drug Name                                        Description  \\\n",
       "6568   methylphenidate  Methylphenidate is a central nervous system st...   \n",
       "14609  methylphenidate  Methylphenidate is a central nervous system st...   \n",
       "14733  methylphenidate  Methylphenidate is a central nervous system st...   \n",
       "470    methylphenidate  Methylphenidate is a central nervous system st...   \n",
       "13224     rosuvastatin  Rosuvastatin, also known as the brand name pro...   \n",
       "13989    buprenorphine  Buprenorphine is a weak partial mu-opioid rece...   \n",
       "904      buprenorphine  Buprenorphine is a weak partial mu-opioid rece...   \n",
       "906      buprenorphine  Buprenorphine is a weak partial mu-opioid rece...   \n",
       "907      buprenorphine  Buprenorphine is a weak partial mu-opioid rece...   \n",
       "908      buprenorphine  Buprenorphine is a weak partial mu-opioid rece...   \n",
       "\n",
       "       Description Length  \n",
       "6568                  677  \n",
       "14609                 677  \n",
       "14733                 677  \n",
       "470                   677  \n",
       "13224                 568  \n",
       "13989                 567  \n",
       "904                   567  \n",
       "906                   567  \n",
       "907                   567  \n",
       "908                   567  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df['Description Length'] = merged_df['Description'].apply(lambda x: len(str(x).split()) if pd.notna(x) else 0)\n",
    "merged_df.sort_values('Description Length', ascending=False).head(10)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA+0AAAIeCAYAAADONu4QAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjAsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvlHJYcgAAAAlwSFlzAAAPYQAAD2EBqD+naQAAgZdJREFUeJzt3Qm8VVP/x/Ffg9Kc5qIJhTSg6EmhFBHRYCwq9UQkFEmGKEMpkSgZGkQZIiH0aKCigSLRQyopafIYGjWf/+u7nmed/z6n23Tvuffse+/n/Xqdbme49+67zz57r99av/VbOSKRSMQAAAAAAEDo5Ez2BgAAAAAAgJQRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAJBJ/fzzz5YjRw4bM2aMhVnDhg3dLbvKLO8TACCcCNoBIIOp8X44t08//TTdt+W5556zK6+80ipUqOB+Z4cOHQ742r/++stuvPFGK1mypBUoUMAaNWpkX3311WH9HgVs+vlVqlRJ8fmpU6dG/+633nrL0sOHH35oDz300GG/Pgzb7I0fP96GDBliWV2lSpWi+zRnzpxWtGhRq1Gjhjvu5s+fn+zNCxV/fPp9VbhwYTvppJPs+uuvd8dmovavXnvrrbfu9/jmzZutb9++VqtWLStYsKDly5fPqlevbr169bK1a9cm/O8FgOwsd7I3AACym1deeSXm/tixY10jO/7xU045Jd235fHHH7ctW7bYWWedZevWrTvg6/bt22eXXHKJffPNN9azZ08rUaKEDR8+3AUOCxcuPGBgG3T00Ufb8uXL7YsvvnC/L2jcuHHu+R07dlh6UdA+bNiwIwrck73NwaD9u+++szvuuCPm8YoVK9rff/9tRx11lGUVp512mt15553u/zo2v//+e5swYYK9+OKL1r17d3vyyScts0mv9+m4446z/v37u/9v27bNHasTJ060V1991a666ir3Nf53JmL//vTTT9akSRNbvXq16/RT0J8nTx5bvHixjRw50t555x378ccfE/q3AkB2RtAOABnsuuuui7k/b948F7THP54RZs6cGR1l12jZgWgkec6cOa5xf8UVV7jHFBRUrVrVHnzwQRdUHsoJJ5xge/bssddeey0mAFbQq0a+OgXefvttC5Owb7PeN3UcZCXHHnvsfp8FdS61adPGnnrqKddBdPPNNx/w+/V+qZNJQWRYpNf7VKRIkf321YABA+y2225znWoaWde+S/T+bdWqlW3YsMFlAzVo0CDm+UcffXS/35la6ohQVg8AZHekxwNACKmxqtGw8uXLW968eV3a6xNPPGGRSCTF1FWN+uo1Cgxq165ts2bNOuwRQP2MQ1HQXrp0addY95Qmr8D93XfftZ07dx7W77v22mvtjTfecEGV9/7779v27dvdz0rJ119/bRdffLFL/1XHQuPGjV1HR9Du3btdqq4CDu2D4sWLu2DCpwkr7V+j7BKcgpBe2/zrr79ax44d3T7T+3fqqafaqFGjYl6jgEfb8Oabb7pAR6Om2nb9fRox9ZTN8MEHH9iqVaui261g7GBzpWfMmGHnnHOOC3iUAn355Ze7EdUgZRzoe/W7tH/0OgWBN9xwg/vb4mnUVseW0qCLFStm11xzjf3yyy/7ve6FF15wnR16nTo6Zs+ebWmln6VMFP1e7Sv/OfB/vz4bmj6g36v9/e9//9vtEz2n16S03+Onn+j4OP7442O2O6W5+M8884x7P/Pnz2/HHHOM1alT55CdVim9T9rnOp51rLRo0cL9X5+pu+66y/bu3ZvqfZUrVy4bOnSoVatWzZ599lnbtGlTqvdvStRJpYyb++67b7+AXfQ51c8IUmefP3aUpaNOA/3dQX5/rFixwpo1a2aFChWytm3buuf0Hij1Xlk9Z599tvs5lStXthEjRsT8jCN5z5ctW2atW7e2MmXKuM+dPn86pg9nfwFARiNoB4CQUYP5sssuc6NeF110kUtXVUCutPQePXqkOFqutGk1hPv162e///67+z6lUyeKAuczzjjDzYMNUnCjAO9wU2E1mqc0/GDjWQGPAtVSpUrt9/olS5a44FNBwt13320PPPCArVy50jXig3NwFYAqaNc8ewUqCiiUQeDn3N900012wQUXuP8rOPG39NhmjUD+4x//sGnTprkOlaefftpOPPFE69SpU4rz0jUyqlF7BWu9e/d2HRI+WBH9LUppVrDjt/tg89v1e5s2bWobN250+0XHjLIk6tevv18wI+p4UJq00qz1fwU+2pdBCsLatWvnOkV0POp4mz59up177rmu1oGn1GjtawVCAwcOdL9Tx3JKwf2RUkDXsmVLF+wpKA8aPXq0C6aVpj148GAXfB5pbQe9VwrctN065hRIr1mzJuZ1SiHXKLYCYr0H2k96b1I7317Bud4rdTKp4+G8885z26+Oj7RQ4K7OJn02P/vsszTv36D33nvPfdXc+cOh40nHlbZJx1jnzp1dCr8C/uCx40fxtT/0udL+UFDt/fnnny6YV/Cv90jvlTIC4jvDDseuXbvc79FnrVu3bq7DRseO0v7jtwkAQiECAEiqrl27algren/SpEnu/iOPPBLzuiuuuCKSI0eOyPLly6OP6XW6LViwIPrYqlWrIkcffXSkZcuWR7QdBQoUiLRv3/6Az3Xs2HG/xz/44AP3+6dMmXLQn33eeedFTj31VPf/OnXqRDp16uT+/+eff0by5MkTefnllyOffPKJ+1kTJkyIfl+LFi3c8ytWrIg+tnbt2kihQoUi5557bvSxWrVqRS655JIj2s+Hktpt1uvKli0b+c9//hPz86655ppIkSJFItu3b3f3/feecsopkZ07d0Zf9/TTT7vHv/322+hj+tsqVqy43zauXLnSvXb06NHRx0477bRIqVKlIr///nv0sW+++SaSM2fOSLt27aKPPfjgg+57499XHTfFixeP3v/5558juXLlijz66KMxr9P25c6dO/r4rl273O/V7w/+PS+88IL7Pdqfh6K/8WDv41NPPeV+1rvvvhvz9xcuXDiycePGmNdqn+g5vSbI73d9FW2r/t4zzzwzsnv37ujrxowZs992X3755dFj4kik9D7ps6bH+vXrF/Pa008/PVK7du0jOj5T8s4777ifr+MptftXdF+fneD26Tg+HP6YqF69euTvv/+OPj558mT3c/v06bPf/rjnnntS/Fv13ODBg6OP6X3zx7p+z5G8519//fV+n1sACDNG2gEgZFQwTaNSGtELUrq82tAfffRRzOP16tVzo0+eRpiVDv2vf/0rTWm2QSqipbTjeH6erp4/XBq51kibRruUdq+/VSN88bTtH3/8sRvxVNqyV7ZsWfczNIKoCtai1G6NyivlNT0c7jbr/VH6cPPmzd3///Of/0RvGtlT6m18xX2lowfnX2uUVzTqd6SUEbBo0SKXahwcba5Zs6bLNNCxFa9Lly4x9/X7la3h963+bk0N0Ghp8O/RaLpG3j/55BP3ugULFrjRff284N+jbVHafSL4ugvKDAjSiKxSy1ND262/VyPAuXP/f6kfZTso/T1Ix5lG37/88ktLlJT2f2re+8PdV2n9Hh0XSl0/HP6YuOWWW2Lm9KsWxMknn+ymfcQ70Hx6vTfK4vB0jOm+fr7S5o+EPx51jkxpKggAhA1BOwCEjOYulytXbr+Gsa8mr+eDUqrcrgJxaoz+9ttvCdkmzSFNad66r5yu5w+XnzeqzgfNxb/00ktTDAK07fobNDUgnvaFAkmfdq1pAUpr1d+tJaw0lUCVrBPlSLZZ26H0ZgWRwZuCc1GQEaROliAfKCod+Ej5Y+NA+0zBtuolHMnvV0eIOiB0nMX/TZon7/8e/7vjj0dVLw92uqTF1q1b3df4fa/5zanlt1tTGOKDRF87wNNyZgpsNS1Ef2fXrl3t888/T/XvViAb39mg/Z+a9/5w91Vav0dz1g+3I+Bgx6OC9vhzmfa50t5TonNifFE6fd4lpWkfB6PjRdNGXnrpJTftRB1qSpFnPjuAsKJ6PADgkDS6ndKScP4xNaiP5GdpTrrm7irgSUT1dc2tVgErFcXT6Lwa46oJoEJV//znP9P88w93m32xOtUXaN++fYqv0ah3kEbtU3KwYmCJdKjfr79JRbzUYZHSaw+26kCi+ToN8QF2Sp1GByo0mJbsE3V8LF261CZPnmxTpkxxx4GqtPfp02e/OgBp2ffpua/S+j0KtlXjQh1mKpSZSMrmia+bcSSO5D3XZ1lZIP6cocwmzbnXPPcDdRwAQLIw0g4AIaOK7mvXrt1vNOuHH36IPh+UUkq4CsOpunVqU4bjqdiW0rqDFdRFBbj0e/yI15Gkm6s6t0btVFwqJdp2/WwFSfG0L9S4DwYNSgfXaLaWZ1NAoeA4uCb74VaLT+s2a5RSQYLWsU7pllLxukM53G33x8aB9plGFY90CS1VZFcAr9HJlP4eFd0L/u7441GV/VU8MK00CqyCfXrPfdbJwfiMgfjCYvGju367gxX7fVG0lEZwtf+uvvpqV/xO65Qr1VuF+nzWSRjo+FOxRH1+Uqrwnpb9q6kffjWBtByPeiz+XHYwOifGZ4n4Apg+I+Jw33NPWTn333+/W21Dn20V4YuvSA8AYUDQDgAho4BQjW5VQQ/SyLGCNy1/FjR37tyYedIKWDV6dOGFFyZsJE9rs6squuY3e0q11lJOasSnNN/9UD9P67trlPJA62lr2/U36G8JBk/aDgUkCkYUQIvmJMeP/mq0MJjS74PV1FaHPtxt1vxqjcCmVL0/tdMVtO2Hk7qrjAB1sLz88ssxf6e2RaOJB+psOBgt86e/SyPJ8aP/uu/3vZY+U6eFgh7N/Q9WD09rRW7VTFC18j/++MNV0z+cTgx1Nkhw+UN9ruIrs2u7Vb1dleEVqHuaBhGfph5/nOk4UCV57Qd1ToSB/kaNGmvqgr76z0ii9q8+Bwp21VGhc088dTbqZ/h9q04qHRPBz6KyNrR96vA4XHpvnn/++eh9HWO6r2PO1/Q43Pdc8/KD77Xob1JH4OEuXwkAGYn0eAAIGQXBWrpMDV8Fq7Vq1XIBl4JXLbXlG6ae1i/WnEw10BU8K6iUw0nX1XrjWk5NFHRoHvgjjzzi7mupLp/KrYa6RlQ1kq3loDRiq9+jBnFq0oJVCCo4Cn4g2hatta4AXcWsNOdVDXU1rLXsk6fASenrarxrxF0FsFQwTst4eb5hr/2k/aVAVHPVE73NWsJNxdnq1q3riptp2xQMqWNFy7Hp/0dK26614jUP98wzz3SdEn7EM96gQYNcx44KFGqZOQVkWg7tcLc/no43vQ9ajk7HowoDKptAo+camdVSWVquTnPX9ToVBzv//PPdaLReoxHpI5nTrtFOP4qr0V8db+ocWr9+vSvGGCxGdjBaS13HrLZb+1zHxeuvv75fsKbAW/tFS39pu1VwT3+nOhv0twcDWHUiqQCflrIrXbq0CzzVuabg80jmjieKOnL8vlL9B2ULqGNNU0V0bD/88MMJ3796n/U7lGWhaSnaX9ofelzFINWhphFvBfV67PHHH3fnDS1np2Xo1OmmZRA1Ot69e/fD/ls1BUc/S++NMnv0eVDRRQXk+j1H8p7PmDHDnRuuvPJK97P0vJZS9J1uABA6yS5fDwDZXUpLkW3ZsiXSvXv3SLly5SJHHXVUpEqVKpFBgwZF9u3bF/M6vxzTq6++6l6TN29etySTX9roUPwySyndgstTyR9//OGWM9PyWPnz53fLMH355ZeH9XsOtTyVpLR8mnz11VeRpk2bRgoWLOh+b6NGjSJz5syJeY2WxzvrrLMiRYsWjeTLly9y8sknu6XI/FJQsmfPnki3bt0iJUuWdEvnHeoSmJZt3rBhg3tfypcv796/MmXKRBo3buyWPzvU96a0PNjWrVsjbdq0cX+fnvPLv6X0Wpk2bVqkfv36bl9oObTmzZtH/v3vf8e8xi/59ttvv8U8fqBls95+++1IgwYN3PJ/umkf629cunRpzOuGDx8eqVy5sjsWtVTerFmz3L483CXf/PGn90jbrvegc+fOkfnz5+/3ev/367OREi0V2KRJE7ctpUuXjtx7772RqVOnxiz/5Q0dOtT9fr1Wx9Lnn3/ull676KKLoq95/vnn3VKD+gzodSeccEKkZ8+ekU2bNqVqyTftx3j+fTkUvwyav+nzoXPAddddF/n4448Tsn9TWvLN09KHWrKtRo0a7nOpZSa1tFvv3r0j69ati3ntG2+84c5L2mfFihWLtG3bNrJmzZqY1xxof/i/VduppS3r1avnfpf+lmeffTZV7/lPP/3kljrU+6efpW3SeUWfGwAIoxz6J9kdBwCA1NEooCpYx6fSA0gb1W9Q6rWmByh1HsmjLBpNx0lpygkAZAfMaQcAANmaisjFj2GMHTvWpVgrYAQAIJmY0w4AALI1LfOl+dWa46yidKo/MHLkSFcvQo8BAJBMBO0AACBbU1E0LXU2dOjQaAGzdu3auaKCB1opAACAjMKcdgAAAAAAQoo57QAAAAAAhBRBOwAAAAAAIcWc9v8t67J27VorVKiQWz4JAAAAAID0pJnqW7ZssXLlylnOnAceTydoN3MBuwrQAAAAAACQkX755Rc77rjjDvg8QbuZG2H3O6tw4cLJ3hwAAAAAQBa3efNmN3js49EDIWhXCf3/pcQrYCdoBwAAAABklENN0aYQHQAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUrmTvQGZSe2eY5O9CZnCwkHtkr0JAAAAAJAlMNIOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEVFKD9v79+9uZZ55phQoVslKlSlmLFi1s6dKlMa/ZsWOHde3a1YoXL24FCxa01q1b24YNG2Jes3r1arvkkkssf/787uf07NnT9uzZk8F/DQAAAAAAWShonzlzpgvI582bZ1OnTrXdu3fbhRdeaNu2bYu+pnv37vb+++/bhAkT3OvXrl1rrVq1ij6/d+9eF7Dv2rXL5syZYy+//LKNGTPG+vTpk6S/CgAAAACAxMgRiUQiFhK//fabGylXcH7uuefapk2brGTJkjZ+/Hi74oor3Gt++OEHO+WUU2zu3Ln2j3/8wz766CO79NJLXTBfunRp95oRI0ZYr1693M/LkyfPIX/v5s2brUiRIu73FS5c+ICvq91zbAL/2qxr4aB2yd4EAAAAAAi1w41DQzWnXRsrxYoVc18XLlzoRt+bNGkSfc3JJ59sFSpUcEG76GuNGjWiAbs0bdrU7YAlS5ak+Ht27tzpng/eAAAAAAAIm9AE7fv27bM77rjD6tevb9WrV3ePrV+/3o2UFy1aNOa1CtD1nH9NMGD3z/vnDjSXXj0a/la+fPl0+qsAAAAAAMgCQbvmtn/33Xf2+uuvp/vv6t27txvV97dffvkl3X8nAAAAAABHKreFwK233mqTJ0+2WbNm2XHHHRd9vEyZMq7A3F9//RUz2q7q8XrOv+aLL76I+Xm+urx/Tby8efO6GwAAAAAAYZbUkXbVwFPA/s4779iMGTOscuXKMc/Xrl3bjjrqKJs+fXr0MS0JpyXe6tWr5+7r67fffmsbN26MvkaV6DWRv1q1ahn41wAAAAAAkIVG2pUSr8rw7777rlur3c9B1zzzfPnyua+dOnWyHj16uOJ0CsS7devmAnVVjhctEafg/Prrr7eBAwe6n3H//fe7n81oOgAAAAAgM0tq0P7cc8+5rw0bNox5fPTo0dahQwf3/6eeespy5sxprVu3dlXfVRl++PDh0dfmypXLpdbffPPNLpgvUKCAtW/f3vr165fBfw0AAAAAAFl4nfZkYZ32xGKddgAAAADIguu0AwAAAACA/0fQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASOVO9gYAB1O759hkb0KmsHBQu2RvAgAAAIB0wEg7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEglNWifNWuWNW/e3MqVK2c5cuSwSZMmxTyvx1K6DRo0KPqaSpUq7ff8gAEDkvDXAAAAAACQhYL2bdu2Wa1atWzYsGEpPr9u3bqY26hRo1xQ3rp165jX9evXL+Z13bp1y6C/AAAAAACA9JPbkujiiy92twMpU6ZMzP13333XGjVqZMcff3zM44UKFdrvtQAAAAAAZHaZZk77hg0b7IMPPrBOnTrt95zS4YsXL26nn366S53fs2fPQX/Wzp07bfPmzTE3AAAAAADCJqkj7Ufi5ZdfdiPqrVq1inn8tttuszPOOMOKFStmc+bMsd69e7sU+SeffPKAP6t///7Wt2/fDNhqAAAAAACyQdCu+ext27a1o48+OubxHj16RP9fs2ZNy5Mnj910000uMM+bN2+KP0uBffD7NNJevnz5dNx6AAAAAACyaNA+e/ZsW7p0qb3xxhuHfG3dunVdevzPP/9sJ510UoqvUTB/oIAeAAAAAICwyBRz2keOHGm1a9d2leYPZdGiRZYzZ04rVapUhmwbAAAAAABZcqR969attnz58uj9lStXuqBb89MrVKgQTV2fMGGCDR48eL/vnzt3rs2fP99VlNd8d93v3r27XXfddXbMMcdk6N8CAAAAAECWCtoXLFjgAm7PzzNv3769jRkzxv3/9ddft0gkYtdee+1+368Udz3/0EMPuYrwlStXdkF7cL46AAAAAACZVVKD9oYNG7qA/GBuvPFGd0uJqsbPmzcvnbYOAAAAAIDkyhRz2gEAAAAAyI4I2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCKqnrtAMIn9o9xyZ7EzKFhYPaJXsTAAAAkA0w0g4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEglNWifNWuWNW/e3MqVK2c5cuSwSZMmxTzfoUMH93jwdtFFF8W85o8//rC2bdta4cKFrWjRotapUyfbunVrBv8lAAAAAABksaB927ZtVqtWLRs2bNgBX6Mgfd26ddHba6+9FvO8AvYlS5bY1KlTbfLkya4j4MYbb8yArQcAAAAAIH3ltiS6+OKL3e1g8ubNa2XKlEnxue+//96mTJliX375pdWpU8c99swzz1izZs3siSeecCP4AAAAAABkVqGf0/7pp59aqVKl7KSTTrKbb77Zfv/99+hzc+fOdSnxPmCXJk2aWM6cOW3+/PkH/Jk7d+60zZs3x9wAAAAAAAibUAftSo0fO3asTZ8+3R5//HGbOXOmG5nfu3eve379+vUuoA/KnTu3FStWzD13IP3797ciRYpEb+XLl0/3vwUAAAAAgEyVHn8o11xzTfT/NWrUsJo1a9oJJ5zgRt8bN26c6p/bu3dv69GjR/S+RtoJ3AEAAAAAYRPqkfZ4xx9/vJUoUcKWL1/u7muu+8aNG2Nes2fPHldR/kDz4P08eVWbD94AAAAAAAibTBW0r1mzxs1pL1u2rLtfr149++uvv2zhwoXR18yYMcP27dtndevWTeKWAgAAAACQydPjtZ66HzWXlStX2qJFi9ycdN369u1rrVu3dqPmK1assLvvvttOPPFEa9q0qXv9Kaec4ua9d+7c2UaMGGG7d++2W2+91aXVUzkeAAAAAJDZJXWkfcGCBXb66ae7m2ieuf7fp08fy5Urly1evNguu+wyq1q1qnXq1Mlq165ts2fPdunt3rhx4+zkk092c9y11FuDBg3shRdeSOJfBQAAAABAFhhpb9iwoUUikQM+/69//euQP0Mj8uPHj0/wlgEAAAAAkHyZak47AAAAAADZCUE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhFTuZG8AAGR3tXuOTfYmZAoLB7VL9iYAAABkOEbaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAACCkCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAAyEpB+08//ZT4LQEAAAAAAGkP2k888URr1KiRvfrqq7Zjx47U/AgAAAAAAJAeQftXX31lNWvWtB49eliZMmXspptusi+++OKIf86sWbOsefPmVq5cOcuRI4dNmjQp+tzu3butV69eVqNGDStQoIB7Tbt27Wzt2rUxP6NSpUrue4O3AQMGpObPAgAAAAAg8wftp512mj399NMugB41apStW7fOGjRoYNWrV7cnn3zSfvvtt8P6Odu2bbNatWrZsGHD9ntu+/btrnPggQcecF8nTpxoS5cutcsuu2y/1/br189tg79169YtNX8WAAAAAAChkjtN35w7t7Vq1couueQSGz58uPXu3dvuuusuu/fee+2qq66yxx9/3MqWLXvA77/44ovdLSVFihSxqVOnxjz27LPP2llnnWWrV6+2ChUqRB8vVKiQG/EHAAAAACArSVP1+AULFtgtt9ziAnONsCtgX7FihQu2NQp/+eWXJ25LzWzTpk0u/b1o0aIxjysdvnjx4nb66afboEGDbM+ePQf9OTt37rTNmzfH3AAAAAAAyBIj7QrQR48e7dLVmzVrZmPHjnVfc+b8bx9A5cqVbcyYMW6+eaKo4J3muF977bVWuHDh6OO33XabnXHGGVasWDGbM2eOG+1Xiry28UD69+9vffv2Tdi2AQAAAAAQmqD9ueees44dO1qHDh0OmP5eqlQpGzlypCWCitIp3T4SibjfHaRieJ6K4+XJk8cVxlNgnjdv3hR/ngL74PdppL18+fIJ2VYAAAAAAJIatC9btuyQr1Hw3L59e0tUwL5q1SqbMWNGzCh7SurWrevS43/++Wc76aSTUnyNgvkDBfQAAAAAAGTqOe1KjZ8wYcJ+j+uxl19+2RLFB+zqJJg2bZqbt34oixYtcmn6GukHAAAAACDbjbQr9fz555/f73EFyjfeeONhj7Bv3brVli9fHr2/cuVKF3RrfrrS7q+44gq33NvkyZNt7969tn79evc6Pa+R/Llz59r8+fOtUaNGroK87nfv3t2uu+46O+aYY1LzpwEAAAAAkLmDdi25pmJz8SpWrOieO5Lq8wq4PT/PXEH/Qw89ZO+99150XfigTz75xBo2bOhS3F9//XX3WlWE1zYpaA/OVwcAAAAAIFsF7RpRX7x48X7V4b/55pvDSmH3FHiruNyBHOw5UdX4efPmHfbvAwAAAAAgy89p17JrWmpNI95KW9dNReJuv/12u+aaaxK/lQAAAAAAZEOpGml/+OGHXXX2xo0bW+7c//0R+/bts3bt2tljjz2W6G0EACChavccm+xNyBQWDmqX7E0AACDbS1XQriJwb7zxhgvelRKfL18+q1GjhpvTDgAAAAAAkhi0e1WrVnU3AAAAAAAQkqBdc9jHjBlj06dPt40bN7rU+CDNbwcAAAAAAEkI2lVwTkH7JZdcYtWrV7ccOXKkcTMAAAAAAEBCgnatjf7mm29as2bNUvPtAAAAAAAgvZZ8UyG6E088MTXfCgAAAAAA0jNov/POO+3pp5+2SCSSmm8HAAAAAADplR7/2Wef2SeffGIfffSRnXrqqXbUUUfFPD9x4sTU/FgAAAAAAJDWoL1o0aLWsmXL1HwrAAAAAABIz6B99OjRqfk2AAAAAACQ3nPaZc+ePTZt2jR7/vnnbcuWLe6xtWvX2tatW1P7IwEAAAAAQFpH2letWmUXXXSRrV692nbu3GkXXHCBFSpUyB5//HF3f8SIEan5sQAAAAAAIK0j7bfffrvVqVPH/vzzT8uXL1/0cc1znz59emp+JAAAAAAASMRI++zZs23OnDluvfagSpUq2a+//pqobQMAAAAAIFtL1Uj7vn37bO/evfs9vmbNGpcmDwAAAAAAkhS0X3jhhTZkyJDo/Rw5crgCdA8++KA1a9YsAZsFAAAAAABSlR4/ePBga9q0qVWrVs127Nhhbdq0sWXLllmJEiXstddeS/xWAgAAAACQDaUqaD/uuOPsm2++sddff90WL17sRtk7depkbdu2jSlMBwAAAAAAMjhod9+YO7ddd911afjVAAAAAAAg4UH72LFjD/p8u3btUvNjAQAAAABAWoN2rdMetHv3btu+fbtbAi5//vwE7QAAAAAAJKt6/J9//hlz05z2pUuXWoMGDShEBwAAAABAsue0x6tSpYoNGDDAzXP/4YcfEvVjAQBAFlC758Gn1uG/Fg4iWxEAkICR9oMVp1u7dm0ifyQAAAAAANlWqkba33vvvZj7kUjE1q1bZ88++6zVr18/UdsGAAAAAEC2lqqgvUWLFjH3c+TIYSVLlrTzzz/fBg8enKhtAwAAAAAgW0tV0L5v377EbwkAAAAAAEi/Oe0AAAAAACDJI+09evQ47Nc++eSTqfkVAAAAAABke6kK2r/++mt32717t5100knusR9//NFy5cplZ5xxRsxcdwAAAAAAkIHp8c2bN7dzzz3X1qxZY1999ZW7/fLLL9aoUSO79NJL7ZNPPnG3GTNmHPTnzJo1y/2scuXKuQB/0qRJ+1Wl79Onj5UtW9by5ctnTZo0sWXLlsW85o8//rC2bdta4cKFrWjRotapUyfbunVrav4sAAAAAAAyf9CuCvH9+/e3Y445JvqY/v/II48cUfX4bdu2Wa1atWzYsGEpPj9w4EAbOnSojRgxwubPn28FChSwpk2b2o4dO6KvUcC+ZMkSmzp1qk2ePNl1BNx4442p+bMAAAAAAMj86fGbN2+23377bb/H9diWLVsO++dcfPHF7pYSjbIPGTLE7r//frv88svdY2PHjrXSpUu7EflrrrnGvv/+e5syZYp9+eWXVqdOHfeaZ555xpo1a2ZPPPGEG8EHAAAAACBbjbS3bNnSbrjhBps4caJLkdft7bffdqnprVq1SsiGrVy50tavX+9S4r0iRYpY3bp1be7cue6+viol3gfsotfnzJnTjcwfyM6dO13HQ/AGAAAAAECWGGlXuvpdd91lbdq0ccXo3A/KndsF7YMGDUrIhilgF42sB+m+f05fS5UqFfO8tqNYsWLR16REqf19+/ZNyHYCAAAAABCqkfb8+fPb8OHD7ffff49WkldBOD2meedh17t3b9u0aVP0piJ6AAAAAABkiaDdW7dunbtVqVLFBeuah54oZcqUcV83bNgQ87ju++f0dePGjTHP79mzx3Ug+NekJG/evK7afPAGAAAAAECWCNo1wt64cWOrWrWqK/qmwF2UHn/nnXcmZMMqV67sAu/p06dHH9Pcc81Vr1evnruvr3/99ZctXLgw+hotM7dv3z439x0AAAAAgGwXtHfv3t2OOuooW716tUuV966++mpXzf1waT31RYsWuZsvPqf/6+dq3fY77rjDLSP33nvv2bfffmvt2rVzFeFbtGjhXn/KKafYRRddZJ07d7YvvvjCPv/8c7v11ltdZXkqxwMAAAAAsmUhuo8//tj+9a9/2XHHHRfzuNLkV61addg/Z8GCBdaoUaPo/R49eriv7du3tzFjxtjdd9/t1nLXuusaUW/QoIHrFDj66KOj3zNu3DgXqGvkX1XjW7du7dZ2BwAAAAAgWwbtCqSDI+ye5pJrvvjhatiw4UHnwWu0vV+/fu52IKoUP378+MP+nQAAAAAAZOn0+HPOOcfGjh0bE1xrHvnAgQNjRs4BAAAAAEAGj7QrOFc6utLbd+3a5dLYlyxZ4kbaNa8cAAAAAAAkaaS9evXq9uOPP7o55pdffrlLl2/VqpVbr/2EE05IwGYBAAAAAIAjHmnfvXu3q9g+YsQIu++++9JnqwAAAAAAwJGPtGupt8WLF6fP1gAAAAAAgLSlx1933XU2cuTI1HwrAAAAAABIz0J0e/bssVGjRtm0adOsdu3aVqBAgZjnn3zyydT8WAAAACRI7Z7/v9IPDmzhoHYJ+1ns84zf50B2cERB+08//WSVKlWy7777zs444wz3mArSBWn5NwAAAAAAkMFBe5UqVWzdunX2ySefuPtXX321DR061EqXLp2ATQEAAAAAAKme0x6JRGLuf/TRR265NwAAAAAAEJJCdAcK4gEAAAAAQJKCds1Xj5+zzhx2AAAAAABCMKddI+sdOnSwvHnzuvs7duywLl267Fc9fuLEiYndSgAAAAAAsqEjCtrbt2+/33rtAAAAAAAgBEH76NGj02kzAAAAAABAQgvRAQAAAACA9EPQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBWWPINAAAAAMKids+xyd6ETGHhoHbJ3gSkASPtAAAAAACEFCPtAAAAAIDDQnZDxmc3MNIOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASIU+aK9UqZLlyJFjv1vXrl3d8w0bNtzvuS5duiR7swEAAAAASLPcFnJffvml7d27N3r/u+++swsuuMCuvPLK6GOdO3e2fv36Re/nz58/w7cTAAAAAIBsF7SXLFky5v6AAQPshBNOsPPOOy8mSC9TpkwStg4AAAAAgGycHh+0a9cue/XVV61jx44uDd4bN26clShRwqpXr269e/e27du3H/Tn7Ny50zZv3hxzAwAAAAAgbEI/0h40adIk++uvv6xDhw7Rx9q0aWMVK1a0cuXK2eLFi61Xr162dOlSmzhx4gF/Tv/+/a1v374ZtNUAAAAAAGSDoH3kyJF28cUXuwDdu/HGG6P/r1GjhpUtW9YaN25sK1ascGn0KdFofI8ePaL3NdJevnz5dN56AAAAAACyaNC+atUqmzZt2kFH0KVu3bru6/Llyw8YtOfNm9fdAAAAAAAIs0wzp3306NFWqlQpu+SSSw76ukWLFrmvGnEHAAAAACAzyxQj7fv27XNBe/v27S137v/fZKXAjx8/3po1a2bFixd3c9q7d+9u5557rtWsWTOp2wwAAAAAQLYI2pUWv3r1alc1PihPnjzuuSFDhti2bdvcvPTWrVvb/fffn7RtBQAAAAAgWwXtF154oUUikf0eV5A+c+bMpGwTAAAAAADpLdPMaQcAAAAAILshaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAACCkCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAACCkCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQCnXQ/tBDD1mOHDlibieffHL0+R07dljXrl2tePHiVrBgQWvdurVt2LAhqdsMAAAAAEC2CNrl1FNPtXXr1kVvn332WfS57t272/vvv28TJkywmTNn2tq1a61Vq1ZJ3V4AAAAAABIlt4Vc7ty5rUyZMvs9vmnTJhs5cqSNHz/ezj//fPfY6NGj7ZRTTrF58+bZP/7xjyRsLQAAAAAA2WikfdmyZVauXDk7/vjjrW3btrZ69Wr3+MKFC2337t3WpEmT6GuVOl+hQgWbO3fuQX/mzp07bfPmzTE3AAAAAADCJtRBe926dW3MmDE2ZcoUe+6552zlypV2zjnn2JYtW2z9+vWWJ08eK1q0aMz3lC5d2j13MP3797ciRYpEb+XLl0/nvwQAAAAAgCyWHn/xxRdH/1+zZk0XxFesWNHefPNNy5cvX6p/bu/eva1Hjx7R+xppJ3AHAAAAAIRNqEfa42lUvWrVqrZ8+XI3z33Xrl32119/xbxG1eNTmgMflDdvXitcuHDMDQAAAACAsMlUQfvWrVttxYoVVrZsWatdu7YdddRRNn369OjzS5cudXPe69Wrl9TtBAAAAAAgy6fH33XXXda8eXOXEq/l3B588EHLlSuXXXvttW4ueqdOnVyae7Fixdxoebdu3VzATuV4AAAAAEBWEOqgfc2aNS5A//33361kyZLWoEEDt5yb/i9PPfWU5cyZ01q3bu0qwjdt2tSGDx+e7M0GAAAAACDrB+2vv/76QZ8/+uijbdiwYe4GAAAAAEBWk6nmtAMAAAAAkJ0QtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIEbQDAAAAABBSBO0AAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAAAAAACEFEE7AAAAAAAhRdAOAAAAAEBIhTpo79+/v5155plWqFAhK1WqlLVo0cKWLl0a85qGDRtajhw5Ym5dunRJ2jYDAAAAAJAtgvaZM2da165dbd68eTZ16lTbvXu3XXjhhbZt27aY13Xu3NnWrVsXvQ0cODBp2wwAAAAAQKLkthCbMmVKzP0xY8a4EfeFCxfaueeeG308f/78VqZMmSRsIQAAAAAA2XSkPd6mTZvc12LFisU8Pm7cOCtRooRVr17devfubdu3bz/oz9m5c6dt3rw55gYAAAAAQNiEeqQ9aN++fXbHHXdY/fr1XXDutWnTxipWrGjlypWzxYsXW69evdy894kTJx50rnzfvn0zaMsBAAAAAMjiQbvmtn/33Xf22WefxTx+4403Rv9fo0YNK1u2rDVu3NhWrFhhJ5xwQoo/S6PxPXr0iN7XSHv58uXTcesBAAAAAMiiQfutt95qkydPtlmzZtlxxx130NfWrVvXfV2+fPkBg/a8efO6GwAAAAAAYRbqoD0SiVi3bt3snXfesU8//dQqV658yO9ZtGiR+6oRdwAAAAAAMrPcYU+JHz9+vL377rturfb169e7x4sUKWL58uVzKfB6vlmzZla8eHE3p7179+6usnzNmjWTvfkAAAAAAGTdoP25555zXxs2bBjz+OjRo61Dhw6WJ08emzZtmg0ZMsSt3a556a1bt7b7778/SVsMAAAAAEA2So8/GAXpM2fOzLDtAQAAAAAgI2WqddoBAAAAAMhOCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAACCkCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAACCkCNoBAAAAAAgpgnYAAAAAAEKKoB0AAAAAgJAiaAcAAAAAIKQI2gEAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpLJM0D5s2DCrVKmSHX300Va3bl374osvkr1JAAAAAACkSZYI2t944w3r0aOHPfjgg/bVV19ZrVq1rGnTprZx48ZkbxoAAAAAANk7aH/yySetc+fOdsMNN1i1atVsxIgRlj9/fhs1alSyNw0AAAAAgFTLbZncrl27bOHChda7d+/oYzlz5rQmTZrY3LlzU/yenTt3upu3adMm93Xz5s0H/V17d/6dsO3Oyg61H48E+/zwsM8zHvs847HPMx77POOxzzMe+zzjsc8zHvs8nPvcvyYSiRz0dTkih3pFyK1du9aOPfZYmzNnjtWrVy/6+N13320zZ860+fPn7/c9Dz30kPXt2zeDtxQAAAAAgFi//PKLHXfccZZlR9pTQ6PymgPv7du3z/744w8rXry45ciRwzIL9cyUL1/evcmFCxdO9uZkC+zzjMc+z3js84zHPs947POMxz7PeOzzjMc+z3ibM/E+1/j5li1brFy5cgd9XaYP2kuUKGG5cuWyDRs2xDyu+2XKlEnxe/LmzetuQUWLFrXMSgdnZjtAMzv2ecZjn2c89nnGY59nPPZ5xmOfZzz2ecZjn2e8wpl0nxcpUiTrF6LLkyeP1a5d26ZPnx4zcq77wXR5AAAAAAAym0w/0i5KdW/fvr3VqVPHzjrrLBsyZIht27bNVZMHAAAAACCzyhJB+9VXX22//fab9enTx9avX2+nnXaaTZkyxUqXLm1ZmVL8tTZ9fKo/0g/7POOxzzMe+zzjsc8zHvs847HPMx77POOxzzNe3mywzzN99XgAAAAAALKqTD+nHQAAAACArIqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAhM6WLVuSvQkAEAoE7QAAAAiVZ555xh544AFbvXp1sjcFAJKOoB0AkDSsOgogJdu3b7fXXnvNXnzxRQL3kNu3b1+yNwHI8m2Z3On+GxCaE2rOnP/to9mzZ4/lzs1bn9Ef5hw5ckS/xj+OjP0MIDzvA58BACnp1auXFShQwAYMGODOGzfddJNVqFAh2ZuVrfnz9ZIlS+yXX35xHStNmzZ17xMyDu2Z8L4fW7dutb1791qhQoUS/h4RuWWTk6w/cJ5//nn75ptvrHTp0ta2bVs78cQTk7152eYiN3PmTPvwww+tVKlS1qRJE6tVq1aKgTzS9zPw9ttv208//WRnnnmmnXrqqVayZMlkb162vLCNGDHCvvzyS1u/fr01b97c2rdvb/ny5Uv2JoaeP1/8+uuvrqGs/xcpUoRGXCZ4z9atW+c6zLdt22aVKlVK9maFmj+eb731Vvf/gQMHuscJ3JN/HOsa2rNnTxeU5M2b126++WabPHmyu6Yi/QXP9aNHj3ZZKKtWrbIuXbpYlSpV7Jhjjkn2Jmbb9uWjjz5qc+fOtUWLFtkVV1xhDRs2tBYtWiT0lyEL27dvX/T/ffv2jRQoUCBy7bXXRgoWLBg5//zzI5MmTUrq9mUXH374YSR37tyRZs2aRYoUKRJp0qRJZPTo0Sm+T0is4L69++67I8WKFYuccsopkbJly0ZuvvnmyL///e+kbl92pPfh2GOPjdx1112RJ598MpIjR45Iz549I1u3bk32pmUKEydOjFSuXDlSrVo1d0756quv3ON79+5N9qbhAOefd999N/KPf/zDvWcnnXRSpF+/fpE9e/Yke/MyDZ0ndM649957I6tWrUr25mRbc+fOdW2YF1980d3/5ptv3Pn7iSeeiL6G9kzG0DWzTJkyka5du0YuueQS9/l4+OGHIzt27Ej2pmVL9913X6R48eKRN954I/Lmm29G6tWr5871v/zyS8J+B0F7FhY8cS5ZsiRy1VVXRT7//HN3f/369ZHzzjvPBe7vvPNOErcya1Lj2e//NWvWRG699dbIiBEj3P1ly5ZFrrzyysi5554bGTlyZPR7uNAlXrBR/MUXX7gL2/z58939559/PnL22WdHrr/+evf5QMaYPXu2CzjnzJnj7uuclDNnzphOLBzYihUrIhUqVIg8++yzkcGDB0dat27tOqDmzZvnnidwD5+PPvoocvTRR0eGDRvmzjUKcBToTJ06NdmbFjr+Orhu3brIypUrI2vXro0+p+OdwD25dJ5u3769+/9PP/0UKV++vOv89nbt2uW+0p5JX+oE1HVg0aJF7v7MmTPdOeWtt95K9qZlS0uXLo2cccYZkU8++cTdnz59eiRfvnyRUaNGufuJ6qAlaM+CFAhu2rQpev+5556L1K1b1wUowQugLnoNGzZkxD2BJkyYELPvFSi2bNnS7f8FCxZEH1fgfvXVV7vA3X+okTjTpk2Luf/KK69ErrjiCtdxFTx5at/rc9GuXTtG3DPIe++95zoM/edFWT++Q+vPP/+MfPnll0newvAJNoAVtN9+++3R+9999507l5QqVSoauDOCm3zBzpMuXbq4URh/3T3hhBMiN910UxK3LtzHuTJJTj/99Ejp0qUjZ555putYjQ/cH3jgARfUI2Opw+Tiiy+O/Prrry5ovPHGG6Pvm0YX77nnnsju3buTvZlZ3pgxYyKXXnqp+/+4ceMihQoVigwfPtzdV8aa2jN0nGScH3/8MXLiiSdGtmzZ4s5fatco9pLt27dHXn311cjq1avT/HuYAJfFDBs2zKZOnWoFCxaMPqZ5Rps2bbJvv/3WFixYEH1c88LGjh3r5ihpWZVZs2YlaauzhmnTptlzzz1nmzdvjj6mYhRr1qyxxYsX21dffRV9XLUEHnvsMStfvrwNGTLEXn311SRtddbTp08ftz//1ynpHlPRHB3fX3/9tW3YsCH62htuuME6d+5sK1eutLvvvtt+/vnnJG559pA/f377888/3Zz2Tp062aBBg9w8Vfnss8/s/vvvd58ZxM4j1Xldx6jmzC1btix6bKsug475Ro0aWatWrezzzz+3XLlyJXuzs6WhQ4dagwYN3P81x1FzT3fv3m3z58+3ihUrumvD2WefbY0bN3bXCtFX1TuBueN8+vTp1qZNG1fj4qWXXrLrr7/eZs+ebeedd557TY8ePdznQOcNnedVWBcZ54ILLrC///7batSo4WrzqE6SPxfp3LN27VrbsWNHsjczy1fpVy0YHfuaP6257CrWqNoC8tZbb7m57iqIhsTzx3uwWrzei6OPPtqdzzt27GiPP/64e19EsdekSZNcTZNE/HJkMX6URekySoMXpeRpHq/mP/oUeU+91UrfZnQmbdS7vGHDhujo1x9//BGd89WoUSOX0fD+++/v1zvXsWPHyM8//5yUbc6Kvv/++2hP/7fffhszJ1I9oRqljO/xVKqxRr5ILU6c4L4M/l/TRS666KJI3rx5Iw8++GD08b///jty2WWXRdq0acMIQQo1MZRqV79+/Ujt2rUjefLkcel3QRpZ0QhYlSpV3L5kH2Y8vSclSpRwx3HQQw89FLnuuuvcNAaNuvvPg0ZglGr8yCOPMDr5v5F21bno0KFD9DHtK7VZKlWqFOncuXP0cU1v0vUT6cOfP3Q9VQaPvoraNcpaK1eunMtgE7V7NAJfsmRJMtYS7EBtEmXsaGqCUuKDU8t07tc0wH/+859cA9L5/di8eXPM/U6dOrn3o0+fPtHHtm3b5t4P3RLRviRoz0KCF33NldNF7v77749s3LjRPaa5LyeffHKkefPm+wXuHoF72ve95nkppU+NMaX7+jR5Be5qVMcH7n4OGBJLKUrVq1ePvPzyy9HH1DhW2uWdd965X3EQf4EjcE+7YGNBKXvqKFFj3HdqqVBLjRo1Ipdffrmbg/faa69FmjZt6h7znyXeh//6/fffXXGhF154IXp+0XQOFRWdNWtWzGt/+OEH1ymC5NZsUHCuRpo3fvx418A+66yzoh20Ou8r0KlYsWJk+fLlSdzicFGNBk0biz+fPPbYY5EGDRpEO8OR/t5++21XdE7TOY466ijX8S1qU15wwQWRU0891QXqer90HPuCmEj8dVTp1b1793ZTEPy0EF1bVR9GHYE6h6jdrzZm8DpK4J4+dD5SoTm1YXwRxp07d7oO28KFC7vYSwV3NVinz4lv56e1XUPQnkWk9MHs3r27ayRoNCsYuGvEvUWLFpEZM2YkYUuz9v5Xg03BoEZWzjnnHFegxTcyfOCuThNdDJG+VHBOIwKaP+1HBHzgroIhqrwan+HABS7tgvtQnwMFl9dcc41r/Kkx4QNNBTJ6f/Lnz+8afao34C9sdB5Gohk7GlWvWrWqa6x5Op8rcNe+++yzz5K6jdifjnEF7mpAewMHDowcf/zx7hqgz4NqnajScHYNdA50rtWoobJJ4uuSaN6u9p/v+EP6vCf+fVH9I3V6v/TSSy5bcMiQIW4U0ddmUO0eFRNVIP+vf/0rIfN1kfLnQ8F60aJFXf0dZfIoG23hwoXueqnOXHWYHHPMMZHTTjvNtS+5jiZeMNh+5pln3CpEakuqDaOgXB0nXq9evSIXXnihqzmgwQrfgZKIbCqC9ixGIzL9+/eP3ldgogAlPnDXB1y9QEgcVY30FYG15IbeBy3xEwzcVWRLI72qHq+CFUiMA/Vean+rSJdGaIKBu3pJVcxIafFIH0rf03Huq/WrAaGCjArcNXUn+Dp9XnwjhTThWN26dXPnFRXgCvrtt9/c1Bo9p2WYEB46hhW4q5CaMkg8dbyogJpGY7TkmzIjsiv/edeooVKqlVEi2ic6T6gT7+OPP46+vkePHq4jPFjoFYkR3xGiIPzxxx93gYhGD4MdKj5wDz6OxAoG2wrOFRj6c7yKRmsgQiO8vrixgnT9X1lWXEfT9/1QO3/AgAGRyZMnu/t//fWXy3hQh6KKMgZT5w/0M9KCoD0L0UlUH2Q1BoJ84K5RLx+4q3o5vXCJo9QkVcIONqy1f4OBu0+V10mYOezpE7CrMrlGBlS10zcCNUrgA3elmAWrr/IZSAyNmgfTVp9++mnX+6852MFjXcG5Pg+1atVyI2nxU0PIdPgvjb5+/fXX0fuqOaIlw7TMT3xjW+cWP98UGc8fs8qw0rI/vo6MpBS4Z2e6Pmr5O08ZZ1r1QA1effXHt66RSj3VeUKjhxqxUqZO8DOBxFAarzJCgkG4BnkUnCvD5z//+U/Mca7AXdk/GkFUlXIkjtqQQZrap2NftahU/8LTFEsF7srWCXaAe0wtSwxlNATbNTqfH3fccW5KSHCKsQJ3tTlVMykYuKdHu4agPRNL6YN52223uQ+zDpLgSViBu+ZZq7faB49C0JJ2CkqUuaAlN5RCJj4YUW+nAncFjCpEpA830ofmqas4jlKV1AhUGpkKePkgSCmp+myogFEQn4G00drTCkqC5yN1DqogmtZf9wXT/IVL5yUF83qvWN4tlvaRGsJlypSJNGnSxHU4eRr1UjG6+MCdBlo4lijTvF+dd7TUjzpSfIaJD9yVtprdKcNA02U0NU/XTc3HVbaTRq9uueUWN2/aL4Gq2g3ar2oEKzOKjqn0oaXbFi9e7P4fDMKfeuopF7jr/B5PAYrSg5Xtg8RQO1FtxOD5XO1J1abStTJ4LfCBe+PGjd3UMv/+IXG0T1WXKjiwoME5dXKpva9YKkhte7Utdf7XVKj0QtCeBainTdXh1YB49NFHXWXmlOjid8MNNzCalWAKUJQuo5GCYHXbYOCulEgVblm3bl0StzTrUiEzBekaiVGnlFKTdAHU6Izm3YkCRM0zUoMaieU7CJXC5wv8qYdaDQ6lugar+PsRd52P6DBJmaYwKVNBQY7+HwzcVeQmOL8dyb/+qraAGth6r1588UXXSausN98ppVonGp1Uynd2poBEDWEFfGPHjnV1d4I0FzR37twx1bCRPnRsat66p8wnTT8Inqv79u0byZUrlzum4zEAkVhKbfcp7b7DT5QdWK1aNdd2V42T+JF5ZWHRcZs+fKykTirfdlf7RtXhNaquz0eQ2p7vvPNOurZrCNozORUh0klVlWl1EGm+tHpHlSI/ZcoU15sd7A31ByGBe2LpAz1o0CDXMNM0BC9YEMSnmSHt4i9Smn+ngFzHdfCEqYKLuuApSBQtEcQFLjHUQajK755qOWgUTe+Fbwzq3KNzk1Jd4wN3LzsH7joWgxkI4u9rf2mERSO0wVEWdUbpcWpiJJc/j6g2TPwoujJ81Fnlg1I1xtV5yBJl/91vOobVTlFhLS2JFKT9qU4QjVqxskr60LlanX8qIufTfxU0ar9r9Da4bJvaM2pjjhw5MolbnLUF559rrrSmJQSnWqrYnKa4ahk3DdClhHZN+lCQruxNZQ762g+qw6MpJFqNKz5wT+92DUF7JhMfdOvDrqqdOrA0r1QFEXQxVDqeghWlbKtCbXA9ZAL21PP7Thc1pf2qUI5/TB9oBe6q8hn8INPwSKzg8etPokpZ0lwjzwfpeo8UNMavHcsFLm2UqqpVKBSsqHPQU8qYUoS1BIrSLn3gXqFCBTeKk10rZcfTeSNYqEaFnzQC6bMUgoG7zt9aPiw4n5eMneRX1/aNMk09a9iwobsWB89NQ4cOddcClijbn66JynhSnYbgHHeva9euLnON0dz0LXCpKR2qP+LPJzpna2qOppEFr5kqcKx2pbIjkH40bUSFGDWqrmwdP91S1ImlVRVuuummmOwrJFZ8fKT7muKkaQhq8/g2pwZEFVcpoNfUzIxC0J6JBAMNHTAqeBM/p0jpGWpA6EKog03FEtTrTyXJtAk2yPz8Rd1UCTs4WqAPtAIWpWor1Q+JHyHQVATRHMi2bdu6/yttTL2eChqDnxMd/+ohVYEoJMbff/8d3bc616hQjubXeQpiFKTHB+6ar6oGR3an84c6MIIVm5WaqkaxRlL8PvPHseawa98pcGfuYnL5a8C8efPc+ygjRoxwtQZUPC34GjXA1XGe3TtY/P7QeSO+ovK1117rOjZ83YsglnZLH8FBhDvuuCNy0kknucDdF1DUiHtKgbsyqOI7v5E2wbaKplDqGqACuitWrHDXAhVtDQbumqagwQnfBkL6vR/KfAuerzRlQRmDwcBdI+7KptJ5LKMGQwnaM4ngAaH5FFo/U0VclBL/xhtvREcWRWuzpxQwErgfOZ0wgx9cn1amXk81Qj744AN3olXqkk9/1wda0xM0J1XBCpkNiaGOEc2DrlOnTuT8889374NPFdNzWjNTJ1Uf+CjAUaCjdZEZWU8MnVeuv/766GdC03PUA32wwN2nymvULDunwgepYewL2/hVDlSMS8G5Rln888FKweqU8iPxSN4Iuyqe+8ra/pqqaThqTH/xxRfRYl7qQFTl82Dh1+zG7zMdwzpHaJ916tQpZs66CoQqcFcnBzK240nVyVVfoGzZsi5w98GID9yVKk9HYfrToIKyGYJLHKoQY0qBuzpxuY6mL70Xajfqmqs2j/8MqA6E2pjqjPWfFXV2ZeS0Y4L2TDiPVOmS6uVXMSItu6EKzWoc+wOmQ4cOrmGNtFHqi+Zy+VFaBYZqcKjKpygwVGCuRoc6UWrWrBltgKs4nf8/0s4H3VqjV6sgqNEcX71TjWNd3PReqLaATrg6wfqRBQL3tFGAomBc+1SrVBwqcNfcVKXK63MUzAjKzg2O4DGoUSvVINHUDp9CrRFHFeLS+us+BVIjMJp76jMckPH8tVUd5LomaIRSjelgR22rVq1cTQd14KqTRYEoS5T9d46uzsc6H/hCudpHwSl77dq1c+f0lJavQmIEAwq9J2o3avRc74k6nRS8BwN3tW/UiajzOmuypx8tU6tj/9hjj40WrvTXCQXuKm6s1VY0KBGUna+j6Xld1koV+iyoloNuml6pc5bvUFGxXbV3FIcFpz4x0o79KGhUOqqW4gjS3Dl96H1PtS6GWndTGOVNHV2wlDbm1/XW3FKdJCdNmuTm5SogV4Nb1Zy1jzXXS++BghTmMKYfjWQpYFRHiS5kanQE6T3SCfjTTz91DWZ/MibLJG2CxdLUC61sHs2JPFTgrnR4BTOch1KmBpmCP+3T4Ii7Cs0pi0rTb7S8DHMYw7FChc7xuibo+qD52PHFFfWcUld1W7ZsWSQ702dexRKV7aTsQE/TBVTzRYG79qk/byuLSvN5kVgK/ILviTr/tJyk6gYEqcaAOpqCqfLKkmJqWfrSKK6OfXVs+Sk3vh0jK1eujFxxxRXuNVxH05emWWpQTp1awcfUCdusWTM3+KD3RZ3r+rwko+OEoD3E4j+gOmDUG+fXmVYg4j/Y6ilVIONPAv5g4kOeOmpsqHdNJ0ot96BU32DVTi3roKBRc1pENQTUUaIK5tm9sZZetH6v0sVEowE6aapCczBw1/EeTFcSeqQT2xOt/amgRPtey834wF1z3BW4qzhdMHDPzitWBIuWHejvV+eHCgwFA3c1FHTeUWFLKo4nn6YlqA6Br6Ctc4w6VvxIOlk8KdN+0XQmjbIH6fythrCOfaQfZegoiyFYoV/nIS0/69+T4NRKBSZaplOBiw/ckTgHOk+oY+Tqq6921ft9tkkwcFfnif9/dryOZoRPP/3UdcqqM9aviuP3ubLi9N6MGTNmv+/L6PZlTkNo5ciRw33966+/3NcSJUpYo0aN7MUXX7T169db7ty5bd++fe65YsWKRf9fo0YNy5Url7vvfwaOTMGCBa1NmzY2a9Ysu+WWW+z222+3atWqRffxTz/9ZEuWLLEKFSq4+7Nnz7aKFSvae++9ZyeeeGKStz5r0r4fM2aM2++lSpWye++912rXrm3vvvuuPfLII7Zjxw674IIL7OGHH4457vVZQNrkzPnfS4X2/4IFC6x79+7WrFkz93+9D1u2bLGzzz7bBgwYYFu3brXHHnvMPv/8c/c9ei/UQZwdz0UrV650X/W36/bpp5/anXfeaYMGDXL/l6FDh7p9N2nSJBs+fLj9+eefduqpp1qXLl3srrvusipVqiT5r8Bxxx1nL7/8snXs2NHdL126tBUoUMBdB/zn47nnnnPnov8Nhlh25P9unQN0vt6zZ49VqlTJfv31V/eYf17n77POOsudP3bu3Jnkrc66qlevbvfdd5/lz58/2o7UeUjH70cffeTu582b13bt2uX+rzaOXjdx4kTLkydPUrc9q9HnwV9H33//fXct1Tnj999/t6pVq9oTTzxhLVu2tFatWtnMmTNdu8WfS8qWLeu+lzZ9+qlVq5ZrR2ofq40p2ve6f8opp1idOnXsxx9/3O/7Mrx9maFdBDji3jjNVdfora/aqeWV1OPfpk2b6Hw6jbirMBe91onhe840eq5eN6W8a0kHX9XZpyzpcc1p14i85jJSsCVxgqOz/vOgr5dddplLj/fze/WeaG67KvkrG6JWrVrMv0sHeh9UM0DFtu65557oCI0KLiq9OzjirvRupV5m99FHFQzSaKxW7/BzF/PmzevO1Spko6ViggW5tA+1L++9915XuwHJExzNip9a4+9r+oLPelP6t0ZptBRidt9nSi296qqrXKEz32bR/GmdK4LHteruaL12pi6lP2VBaZqSr9KvZYJ1vfTTKD3VSFKhRUbZ04/aK1rOULV5tCSzplm+8sorrt2pVaH0uShZsqRbBhTpY2+gbRJ/rtf1V+fyl156Kfq42puqkaT57slG0B7ig0lLDOgg0QGkD7KvHKw0YS0zprXYFcRobpgagf7iR/pM2qmBrca15hhpjpdPBfaVsBUYam67HtNJOJg6j8SJD8BVGETH+vbt26OPqYaA5rqrSJTvcKEhmFj+nKILmRp7Pi3Yz3H3xeni11XOzoG7GsqasqQClTqfKOX0hRdecM998803kdtvv91Nd9L53FPleFWt9R2ySN6xrmX4NB1H19jBgwdHOwr9Ma36Mno/NT1HS74tWLAgkt1p2pjSSFU8UVM8PNV8UeCuubmq46D9WrBgQTq6Eyx4vvXXQJ2jdS5SJ6GWplL9EVFQqEEHLWGl90TvjeZVMx0n/aiGg6ry6/qpNoxu2u/qrNVnR9Txpylm8R0qSIzgZ2T48OFu6eCWLVu6to1f6eO+++5zcZemLKj4rt6PYIyVTATtIaUDRaNaKiqnUXVdCHXg+KBRQaIagWooq6qkP5jCcFBldmpsaN9rORRP+9oH7sERd2HOdPrQKKR6NzVy44vpqEGtES59Pg6E9yPt4jv+gnO71MAI9kKrUagKxMp20BzKlL4/u9JoY9u2bV1BOS3/NXv27Ohzqn3hA/fgXDlGuZJPDegiRYq4znKNECtDQo07LdHnaZTYz4H0VZ+zMw0qqGEbXJ4qeO5QJ4hWX9EyYtp38UX8kBg6r/jOkAkTJkRXElLmoNowChI1ICRqT6puz5VXXukepxMlfakWTIMGDdw107fVtUSkagyoHoynTIjs3OGdEe6++26X0aCBUdVHUrtSnex6X5Q1qPO+OhpVtFEZKn4AKdkxFkF7CAQLgfglBbTkgAojeDrJKpVGvf5KzU4JwUraqTNEowT6EMeP9PriW2poB9dRRmLEFyxTerGWvqpcubK70KlzSgWMdJJVR5ZfmgbpR8Gk0luD1HGl98QvpefPYXptdj4HBadxeDqWFegpSNEolpbpjG9gK1NHgZ9fqQLJpSwITX0aMWKEu6/RMC3vowBdKca+0KjOQyralR2zrNShqlTe+GJa6rjzKx0EpzZ5/j5TmNKHAgoF6TpWVcRSX4ODD8HAPdiB6L8X6cNfF7W8p6bweT57Z+HChe4aEL9EJIF7+pg5c2akSpUq0c4rFc7V/g92nuu90SoX+gxp+oIE2zzJQtCeZEpXCi4vIDqZaqTXB+f+ZKq5olo3UymUpDAllhoYmm+negGFCxd2S1d5wQ+qLoRaCk4jvdk5QEm04MXJz432Zs2a5ZY11HQQZZtoOohGvrT8HtKPzjHa37potW/fPjqCplEAVX72QU18Yy87fy4U0CkVXl5//XXXQNaxrZHY1q1bu2BQDecgLXPVu3dvzukhoVEVv4a4Ro8VmHfv3j0yZ84cd95RarefqpYdsyJ0fta5WOdhvx98Z4fWsPfzpnVN9R2wOv41GEEGTvrT+VjvjdqKmroU34bxgbvansp+QOIdKNhWFqfeFw0MxQeRylKJ7whDYuyLO++oboNqCfhsFA2IarUWv3KUBir0OdKqC0qV13n/xRdfjIQBQXuS6cPre9t841c91vpgjxs3LnoC0EGnkUWlcOjCqJRLJJ7mJSp9T50m+jB7wYuegpcDZTsgbQYOHOhqCShNKVikSzZu3OjmkGqUXYGk5pQy2p4YKY2KeeosVGqw5rJr7rqmiqimRpcuXTJ8O8NOc0N1bKpTT+fp4Hx11V3QeVtzS+MD9zD04OO/tOyeXzZVI+sdOnRw12jdVzCk91fnoOw8CqaOu+rVq0fOOuss938fzGserpaf9aPtnlKwNdjACHv6U7q1r3OkjE0/ehsfuFetWtV1xgbrwyCxAaKWDtNAj+rt+Okgw4YNc0GgOgI13UyZOpdcconrCM/O55T0sicwiOCnF2tkXQWkNQ1KAbvmtnsffPCBa+/4Dkl9nvRe6bMUhgKxBO1J0qtXr5igRB9kBSR+lFHVylUkxI/aiA4YVYjXQaWgPtggxJE7UK+/UpUUEGrN0mAWBA3r9H0P1BlyzDHHuI4sZTxoNMBXKo+nz4pGLZkXmXbxI+XKYFBVbE3PUa+zqMdZRVo0bcTP5dWNbIeI61wNFt3SVA4F7Cmt5qF0PAXumt8ePLcjuecfBepq3PkOdNG1WOcgf53W83fccYdbDUDZEdmdGrWqOaLA3Tdw9VlQzQsFIZreNGPGDNfg1Xmdc3XG0bGrYFyZUtr3PnAPnuvViehrxSDx7RlV4i9atKirZ6IOFGWn+M5apVtrPnXZsmXdQJw6w337ksA9cfYG9qUGG3x9B7VltO/VhgmOoOv8r45HXaOD36v2jwaNwoCgPQl0wCgoVOEJX9Dp8ssvd/PBNK9RH16dTFW0Rb07StVT6oZGgHWBVONBH3I1IJC2k6tSr1VES/tSaX0+SFEBKR+4+yWbkH5U0VaFQfxFTRXhFbxrxCAYuAdHatQ4VI8o0tZ5qHRfv1/VwFbjQsXRNCKsETK9F0HqPBw/frx7bzS/PTs3NFasWOECl2Bao4L2OnXquAab0vDia5YocNf0G53D1YtPynByKbjU+6X3Q9kjPgDVqIyWZlKxV6V3awqDsk18hWH8N3DXdLHatWtHR7G04oqWfFMNB302dJ6In6uLxPHnD51XRo4c6ZYJ1lQOf65W21I1GbTaja/No6yH7DyNKT0Ez+Pa/2o/qh2pjhKNqKsTV525H3/8sXvNb7/95l6nzhN//aSuQOLsCRzfqhvjBxo0KOfbnDq/q76DRtyVFaGCgMog8u9DGD8jBO1J+mArrVcHi1JifBq20vCUsqTAXR/idevWudQajbhrTUf1APneODUMdfJF6t8DNaiVGqO5XRpR0T5V4OhTYHTCVeVIPc6amelHnSIKEDV3VPMiPV3UtP6xGoRqMHv+RKpRBPVmZ9eAMa0UqKuzSp0f2o+aGnLhhRe6xp1GHlUJXmnw+nz4QCW4rzVaUKBAgZh5rdmJsnCCve8KTHzgIprioQrkOs8EO5t0Dl+1ahXFLENwDdD5RiuzqMhl165d3dQcnW98lXi9d2poK6unXLly0cAnO+8zZRmoE0Md3qLPv87fCs798a/XagqZjvH4Tj8kngIOjairboY6oHQMK1ARvSeqDq+ARW1IZWlm5+M4van9rra9BnyC2Zlqz2ggTgNvweuEF8YAMSt0oHT/X6aP2vCax+6Pfe1vLYWowoAaMNX7os5G/56F9f0gaM9gwQNBvWwK2nWCVW+/KH3DB+5+hEZrHwd74BRYaiQsuPwMjoz2veat+0wHjZQpANG+1+ihD9xVFFCjYn7eHtKneJdGexXgKEgP0nrVWpu9fPny0UIhChzVW6pGSPzcSRzZRU0plMrk0XlIDQ3N1fXnKH3VPlfgrsd94O4vavqM6ILn1/3NTlSATJ2pGrFS4KegXEGdGse+J98H7hpxV6NaWTxaRqZ+/fqMqISAGm8amVTA7inbSqMtOq799VUFAvVadaJn9/OFRqTUuaq1vbU2vQYaFIDo+ugD9+zaiZfsJWp9YVCdj/TeBDu65ZlnnnHXV6Z2pO+qNwoSlfqu64E/Z/jnNECnddppu2eMBx54wHVS+aUMdd5SR6z4do7iLL1P6oD371OYr88E7UmiXlClLal3R6O96sn3B5MCd6WVaSQrWElbI2FabkwfenpKj5z/QOpDqvmkWk5MNBVB+18NEHWIlChRwo08+iAlOM8RaRM/Ku5PjhqRuemmm1wH1tNPPx3zGp1M1bkS3/NJEbrEvBear6WlaNTbrIZ3kA/cVWNAhVv89BFRZ4o6TrLriLGCc52/1eGkc4UK9vnzSPD8rBoA6pBSRoO+Kh0SyaVAUx1V6qi99957Y55T4K4MK52LVBQW/6WRKnVAqd6FOqmUIaXP/9VXX+0CdQXuqtWgObrZ9ZyQDCqqpUxM35ZRZ6KmNXnBjm2y0hIruD+D5wpNUVBHirJ3ggM+Ch61XKoyVZC+Nm3a5Dpk/ZKcOmdpKk+wfan3L76TMezT1Qjak0DrZipdQ40+jST++uuvrndfaU2+sJOqeuo1wTWS1TDUiDyVy1NPHR86kapRoZOsAng10NTQ9h9sjSSoY0QdK75yPxJ7gVPDT6nZKlikDhSN3mr0Uo0NTVWID9yDQaT/ObwvqZNSw02Bu0aBdeyrYzBYUVj7XI0QdaoEv1eF6vR5ys4UnCtQUQeg0oCVdaCskPjAXcXMNBLGsm7hoONY74muuSoSFT9PXR0w6pBRZ5U6FrP7uUYNYJ2btW6xDw7VyafsHHVEXXbZZS5bTTfVBqDAWfrzx6Sm6Wj/a8qNAkW9T76DW5mC6pQi+yHxgtdCXTt1vgguoafPijJ21KmlNGxld6rjW+ccOk8Sb28K+9QPuPnsQE3/02CDf73ej/jszrAjaE8CHSRKkQwGhAoi9aFXL5wP3LXGZljnVWRWTz31lKvm6QvjqBdOWQ1aJ1PUK6oMCKXVkBKfPrQcllLHFBz6AiFaC1PU6FNwqJTsYNoqEn9h0wiMgkhNTwimyqvTRKtXBAuoBc9VwY4TxAbuCv6CgTsFuMIhpaBbx7DSVdWI1lxfdaAHac62AiH8tzP7zTffdGm9qnehuaGanysqSunnS6sdE+bU0qx4HKsqv4r+5c6d2xVNDNJUP82tpnhi+lF2poq3avAhfkBNRY5VTLpgwYKuXam2jb+ucg1NnL2Bfak2jQr/BbMCPdXn0ZQ20flKWSmZbVUogvYknHC19IAaCn40yx806qVTup5SOJSi5xG4J2burqeq/br5IFHz2PWeqFCIghZlPVA8J31MnTrVnSj9vF8FPGrwqeHnqbNEBUG05nV2H+FKz44TLXmi2hhqcOj49z3T6lRUKrdeEz81hPfj8EfclSqvwlDB5eCQ8fwxq9FzTXtSsKlMH994VjCq0WE14hSQImX+XKBpe9pffvT2tddec5WydV6nkyNjqsSPGTPGtRH98Tp27Fi39rc6uhU4KotQ529la3L+ST8aPdd0EF+tX+cUZQyq9oP/vKiYtKadaWBCWbUSLEyKtNkXaJOo/a72vM+W1dQRrdDiqYJ/ixYt3HW5SpUq0dgrM3U0ErQngU6i6hX1aRqe1l9XmpPSmeiFSxxNMdC8Ul8BXg0LnWjVC6oPvHqjleqn0TEFMMFCUkgsLQeklCTf2FMP9PDhw6MpmH4tXxUGIQ0+cYL7UI09ZTqok1DrKKtAkSpk+1EaXeQUuCvo1HNI3Yi7gkQtH+MbakjueUfFuXR91aoTKk6k1O7vv/8+ei7SHHdl+BC4H5xSgXVc+45tLcmp80RmG7HKjBQMFi5c2GVkKujQMezrB2hKmVZCUIq8gkS9R9Q+Sl+q66A2owbWNF9dS6jqfdH5RZmzPmBUzRhlpzBVIf089NBDbiBCGQ+a7qdOWLVzVA/J1wYbOnSoGyTSe5EZA3YhaE8SzafTB1s9/ypMpLQzpTEF16RmhD0xwYpGbPVB9Wvea76dAnb1tmm/6wOuAEaFAKkXkP71HDQ9QY1oNT58wC6vv/66q1IeLDBH51Xi979qOqgREaRaGfqM6LwkSi1LqfgfDk6NZGVRKVNEq34EM3yQHApqNPry7LPPRh9TLQaNDOt90jVCx/moUaNchyLTog59jGtUV1P8Gjdu7M7jwaU6kXg6RhVcqEixRtUVDOp4bdSokVum0Afuqgyvjli1KSnUmlgptUU0qq5ziwaBVMBYbU1lDepxdYSrM9DTdFeNAGuuO9fVxFq0aJHLnv3oo4/cfY2wq2imOmI1dUSrhOjzo+mwqvngA/XMFrALQXsSaRmgUqVKuZ5R3YK9P4wupl78vlM6meayKFBXg7pLly6u4rOWf1CBLSRecNQleLFTJXgVd1KAqLQxT8GNRsDUKOHYTx/qrFLRRU3B8aPqajz4C9ctt9ziGoDBFSv8a3D41GBWAyKltXiR8RSEK2tEhRPFH++q4KyMN6V7+/OUX+oTB6d0YGWvqQOQ9Ov046+Fmrqn83LLli1jRs810KDARME7nU0ZN2da0w98BpVqwiggV0FAf/7QQJCmkCi7M/i9AwYMoEhjOvjpp58iL774otvXOs8rNd4PCKnNoxH3IUOGxHxPZgzYJYf+MSTN2rVr7ddff7Vt27bZOeecY7ly5bI9e/ZY7ty5k71pmdqMGTPsp59+sn/+85+2b98+u/3222379u02ZMgQe/XVV+2rr76ykSNHutfOmTPH/vGPfyR7k7ME7fPjjz8+en/UqFH23XffWYUKFeyKK66w4447zsaOHWtPPfWUlS9f3u699153/L/00kvuq94XHfs6LeXIkSOpf0tml9I+nDJlitv3X3zxhX388cd25plnus9Hzpw57f7777fPP//cPvnkk6Rtc1axY8cOO/roo5O9Gdn6uPfH9c8//2w1atSw5557zq677jp3fdXzutaee+65Vr9+fevfv3+yNzvT0f7VfuQ8nb4mTZpkd911l5UqVcp++eUXd94+5ZRTos9PnDjRHdt//PGHTZ482cqWLZvU7c3K19H77rvP3n//fVu1apVVqVLFzj//fBs4cGD0tTt37rQ///zTOnfubBs2bLC5c+e688zevXvdV6Tdvv+d1+P99ttvVrJkSbv++uutYMGC9uyzz7rHO3bsaLNnz3Ztz5kzZ2b68xWRYZKVK1fO3Tx9uAnY00b7cP78+e4EO2vWLLvpppts6NChVqdOHRe0P/DAA7Z582bXqH7nnXesRIkSyd7kLOHmm292QbsawGeccYb169fPXdCaNGliw4YNs6lTp1qvXr2sXbt27sQ5evRod9FTg1on1IULF7pjnwtcYi9su3fvtl27dlmBAgXsoosuche0hx9+2G644Qb3HtSuXdt1aClg10UPaUfAntwGthpnOvffeuutVqlSJevSpYv17t3bjj32WGvUqFH09Xpt4cKFk7rNmVVKDWeknR9H07G5dOlSd56+++67XZtFQXnz5s1dMOjP1a1atXLB4muvvebO80jsucQHeQMGDLARI0bYuHHj3PVV742uowrOX375ZfeaN99801588UV3zdX1lIA9/do1H3/8sfu/2u+nnXaa+zxs3brVVqxYYY0bN47u87///tsNVqiTRe9lph8QSvZQP5BeNM9O6zKquJCWF9N8Fy27oTUzPZZCSRwVOFNBP61LqrSwVq1aRauqKqVMS4np/fDL64kKQSntz6cBZtaUpTAJpuMNHDgw0rRpUzctRPPtfM0Grd+rlErV1dBasu3bt3fTc3xVW6YoIDNPO9Pa4b5ejCiFW1NvlDapyvEq6KWlmjTvUamuQNjoHK1aI75gsc7Jup42aNAgUq1atf3mrMdPa0LqqR5J8Frqp+8NHjw4+hpVitf7o7nsWkpYlJqttOzMPGc6M+jZs2ekZMmSrk6VVrrRtANPc9ZVZ0PT/VQMUEUZ/RS/rFAjiaAdWZoKgqhwi6o6ay6vqq76NcGROP5kqA4R7WNd4DQ/Orj2sRrOCtxV7MkXDEnpZyAxVKlWDQo1+lTPoUKFCu4ipsagqPPk0ksvdfN9x40bF/0+qkAjM3fUqk5MsMClp7V79ZlQQ08NOXVkff3110nZTiDojjvuiKnxouXCfO0XFUv0FLjrGqvnatas6VZZQWKpGHShQoViOkX0fqjgnJYMC1Lgrg7vtm3b7teGoRZM4gQHEZYtW+YG4nSuV6ds7969XSeWzu2eAnatFNKuXbtoeyarvB8E7cgW9MHt3r27G1lUo45e6cTxFyr/ddasWW7EXRc+jb4HqXqnqg4reJw3b15Stjc70IVNFW1VHMdTkRztdxXI8VXNtRyiihspgNGSNcIoOzIrVWvWyEvw/B4/2qUCgVquzI+mAcmmVTvil2dTBoiy1dReWbFiRcxzGnHXKiw61unsTix17ikoVJAeDNwVzF9wwQX7LQmsxzVAQWd3+gge39u3b3ftlCuvvNJ1mPjzuSryn3zyyTGr4gRXbslKGQ9MSkKWp86po446yp588kn78MMPXRGuQoUKJXuzstwcI80lWrNmjSuoqDlEmmOkYiCaq+5Vq1bNhg8f7uYgqQga0ofm0WmeuooXieY8au6ujv/vv//ezbuTpk2bWteuXV1NgZYtW9rixYsz93wvZGtbtmyx9evXu3mMnq8RowKLKhKlQl3HHHOMFSlSJIlbCvy/Dh062Omnn24fffSR9e3b1z1WtWpVGzRokJ188smu9ouurZ4K56p46+uvv05tgQRTkb8xY8a4c4SKVGrOuqg2z7p16+z555+3efPmucdUZ0DtSc2XVhsTieePb30uGjRo4IpK6xyfN29e97jO5yr8d+2117oaVXpe8uXLF23/Z6U6YXzakeX54hP+xFuxYsVkb1KWoH3qT6j33HOPXXbZZS4YV9C+ZMkSmzZtmn3zzTeugEswcK9Zs6a78Ol7FfQjbVJaAETBuiqYq1iL6AKn4jhFixa1U0891QU3noq23HjjjXbWWWfRmYVMTYXmfv/9d7d6SPy5Zfz48a7wIgvmICz+l+0a7VjVsavg5LHHHnOPaSUWBZBafUUBi1ZY8W0ana9pyyRO8HyhIFzni2LFikUDd10nVVxXbRkVB1SxXT22ceNGe+aZZ9z3cW5Jn/dDBQBVzLhly5ZWpkwZV4jxjjvuiD6vwF1tGBXa/c9//hPzPmS1QYis0/0AHERW++CGaYRdvf2qnqoT619//eWWeFNFWzWQVTH+wgsvtMGDB9ttt92239J6jBIk7n3QKIAPzkuXLu2qZWu1hOLFi7vq2RoJ0Ou1vGT+/Pljvv/iiy+28847L/o4EGa+AvCPP/7oRrvUQaWgplmzZtamTRu31KeWdtNjOqaVZfXee++5KtxcCxAmOh7Vwa0sKAUeupZq5F3nZi3DWblyZfdYp06d3CjwDz/8ELPiEBJ7HdV7oWumMh9UKV5LiJ199tluaWAFjXo/Vq5c6QJHrUyh90wjuSzVnFj+/Zg+fbrlyZPHtS9btWrlsqV0Xu/Tp4+rEK+2pSiYV5tHHS1Zokr8AXCEAUj1CfXTTz91J1U1hi+//HL3mEZxtQa7ltrTcxMmTHAnWfVexwftSEymwyOPPOJG1bVWqQJ2NfZuueUWd//ee+91DQylwCutT0F9t27d3Pfp+/3FjYAdmYE/Xt966y23frUa3DqmNRo5duxY17jTknt33nlndPRdoy9+2R8gLHQca5316667zp2ntWSVgkR1QqmjVXzg/sILL7jUX017QvpcR7UkrTr3tJ+1z0888UR75ZVX3DK19erVc4G7sgl1UwDvsVRz+lAH1QUXXOD+r4wT0bQFdczqs6PAXe+dppGIOlskqwbsTrIn1QPInFS51hece+SRR2KeU6EnVe/s2rWru68qzVmlemfYPPDAA5HixYtH3nvvPVdZ2C/lpvdA79Gbb77pis+pUnzHjh2zXDVVZD86zgsWLBgZNWqUqyKs80vt2rVd8UVftOuzzz6LTJo0KfL+++9H1qxZk+xNBvajYnNabSWl1Q60NGHOnDndyh9ZsaBW2DzxxBNuGTGtrqJq8UG+YrmK0/36669J28bsRkvQagnPsmXLuiU7g1RIdMSIEW6FhaFDh0ayC7qGAKSK0pE0SqCUJX1VaqpSynxvqArRLV++3N1Xz7TvkVZKExJDc+2U7aA0PhWVmzx5sn399dcuLV7vgXqcr7zySvceBfc7qXzIzHSM165d241Q+gJQX375pXusffv2Nnv2bDcXFQiz1atXu+NX1874VG2lXRcoUMCNvOs1PXv25JydDrS/lb2gTDXV5lFWoOfbKxpxf/XVV11NpO7du9sbb7yR1G3O6lMUPKXF67OhdozO64ULF3bFjUWFRK+66iqXWdi8eXPLLphQCiDVVFROAbsubgoUFy1aFE2RV5VypawGEbAnluanq4aAissp/VcVVPv37+9S41VBW3N5Nf8uuN+zWjVVZE0pFan0VeFVkOuXX36JBuxKJ1Y65NNPP+2OdxXABMJO6fDBlQ50zPu0XnXGqhNKAeKll16axK3M2ucWBYq6PgbPJ/55Pa5zy7///W+XLq/OQBWoQ/oF7G+//bYLzB9//HFXnFFV4DUVQenxo0aNsltvvTX6fRqYaNGihXufNBCRHRC0A0hz4K6icwsWLHAFzdTrqUI6aoz4XlGqqqZflfhGjRq54Fy9zirK4udCrlq1ymbNmmXLli2L+Z4sO9cLWYoacRqJVE0MUfCikTC55pprXGP6iSeecPc1h13UGaWGt78PhFmtWrVcvQXNV/fHvD8/v/vuuy5AVJaUCtAhcXyA+P7777sBBo3oauUUrToRfF7UCaj2jc5FKgCoAFGDFEifVYh69Ohhb775pitwrLalBiW0z1u3bu0KMqpuiTKs4mWXgQiCdgBpprR4NarVK7pp0yZXPOSrr75yF0MViSJQTJvgPtT+1U0KFizoGhLKclCxHKVUihoiKsSljhOl9AGZjUZZHn74YTfiooacskj8NBsVVVQxImX5DBw4MHrMa51rFVTUCAwQdhq9Vce2CmmpmKsCFGWoqSCaRhZ1jJOdlj6BokbWVTxXa3trH2uZPaXIa5Ubf81V2rzOPRpp1znH4z1JHN+uGTp0qAvI9X5osEGFGTXgoFF2LbOnwL5169bu87J27dpsu1xwDk1sT/ZGAMgalB6vkV71kKoRorlgSL3XXnvNBSue1vDV6IBO20qZ1H3RaIzm9Go+XokSJWzx4sVuaRRd7PxSbyyvh8zmp59+clk7n332mTuvDB8+POa5559/3lV39lXilV2iaSJaQxnIDHRuVkqwVlvRHHZliSgo1Lnf14hBYvnq4grQNdVGadfa51qRQo+ddNJJbuRdnd4K3JVFqOtolq5KnkS///67Pfroo1anTh3XUaUK/qrl0K9fP5dxsmbNGjcodPrpp8e8B9mxXUPQDiDhRaLUwD7++OPtwQcftJNPPjnZm5Qpabk8ZSxoyR9dvNTDrJFHFSRSATrdV0q8UsZEI44aqdEIpdIp9X2sH4vMSk0TjZ4rFV6NOmXxaP31YGqkMk6UXqyGXdmyZa1u3bruvANkNho9VKeTAhKNwKvAFhIjPrjzgZ8CQY2kT5061apVq+Zep85AP11BHeB6nuto+ps2bZprt/zxxx9udF0F/7p27erS5BXIqxPliy++cB0q2RlBO4CE06ivgkuNFqgxjSOnXn7tv5tvvtnuu+8+lwavRoQKr4hGFK+++mq77LLLoqON8ajWj8wmfjRLx7DSJJVVonml+jwEA/fsONoC4Mgp7Vpreatwq6eOcXUI+jT5lHAdTRxNO/AF/1KitszIkSPdvHbV7FFmoTpV9B499thj2f594EoHIOHOPPNMF1QSsKc+cNFFqmPHjvbUU0+5eb2qmrpr167oay666CJ3YVMqmV6XUv9rdr/AIXMG7PPmzXOjXX369LEff/zRZes89NBDbjWKF1980S2/JHpenYNqCAJAUHDes7JxNHrbuHFjt8LKnDlz3OMazVUmz9KlS6MBur+W+q9cR9POF8T1AftLL73kVrlRZ6ymhwQL/2l6n64DyqLS6zRlRG2gXBQBZKQdAMLkk08+cfPsNJqoi5rS3c8991zr1q2bm9+rgi1BKp6jAF5zwnr37p207QYSQQ04jaZrXrqCcaVEKtNElYW1lJtWStDSS+oQ1FScmTNnuk5CAEgpA0dLQa5bt87V2lHQN2DAAFc/oGrVqm4qn7LV7rrrLlf8DImnwooKxDXNT+fqBx54wL0n6kDRVD8F9G3btnUFdbWMraY5KXjXOV6DFypqfLDR+eyECRoAEALqP9W6vRoF0Ii65tspONGIgOZ6qbGhYkVFihRxc9u9Cy+80I1MUnwLmd23337rCkGpPoM6qBS0582bNzq6oiWy1ODT8a6Kziogld3nOALYnw/YFTAqO2fEiBEuYFS9gIYNG9ry5cvdc7reaiqanld1cs4niacCcupcVdbgFVdc4TpfP/jgAzvnnHNcwVylwKujViPq6lBRR+24ceNcwK6aJtQU+H+MtANAiKgQy9lnn+3SgjWHy69NrXWpdSHTyIBG1NVrHY8LGzLzHHZ1UCkoVxHGH374wXVINW3a1DW6fbEu1XYAgEPReaRz585unnT9+vVTrJmhaXxz5851wbvmUqtqOVXiE8fvy0mTJrl9rPO3zuMK2lWjx7dtlAb/zDPPuCl/6pwNoqbA/6N1BwAhGyE44YQTXPXgGTNmuPVhlSqvXmhVUdUFUPPwVDlbKWZBBOzIbHQ8a6RFKZJaX33jxo0uZfLiiy920z40AiZag131G9TwK1q0aLI3G0DIqXBl/vz5YwrPeZp2piwenWN0U4e3OslV6FWVypF2wc6PRo0auYBdK4CoQ1bL6Gm/i9o26lTRijeaxx6PgP3/UYgOAEJEAYl6oZUer3lcSgHWCLsoXcyvX6o5YiRKIbP58MMP3bEr/vgdO3as5cmTx3VOqZGtjqrzzz/fFaPzjT7VetByTBzzAA7GnyOU9h4sXBYsMKeOQs2VDlaRL1iwoPseJDZg1yCDioieddZZ9sQTT7jl9YYPH+6m/3nHHnuslSxZ0s1px4ERtANACJUpU8atxa4gRmuxjx492jVANAKpkUiNwuuiSBCDzELHrVZBUMEhzUn3jTo9rvnryjK59tprXbV4dVht377dvvvuOzcdRCnygwcPdqPxAHAgwdFdZfDofOMf103nFa1AobR479NPP3UjwCwfmdj3QLUDtmzZ4rKkRFOeVJNn/fr1dvfdd9uwYcPsrbfesk6dOrmO20suuSTJWx5uHJ0AEFIqmqN5XkrXGzRokFWpUsUFOErj8wE7c++QWWjKhxpoCsRVlEhffQaJ5jcqDVJTQFR8SI1oZZ3ovkbFNNJevXr1ZP8JADIJFXDViK6ul7fffrtb71sF0Vq1auWqk6uwqyiIL1y4sDvn+HnWSLvx48fbpZde6jpOatSoEV2as3nz5vbggw+6UfU77rjDzWfX84sWLWJZt0OgEB0AhJyWq1m4cKEL2Nu3b081VWRqWqpNcxtPO+00t3byI4884gpGaQmg4JJNEyZMsHr16rk5j6VKlUrqNgPIfBTiaJRXq1IoGFRHoFKxJ0+e7LJ5fJGz4BJxSAwV9lNArqK6CtyLFSvmVsbRiLqoE0XnfS1n26NHDzcAQbvm4AjaASCToZoqskLgfuONN7oiUVqbXUH58ccf7xrZvgGtue1q9NGIA5AWKnCm4q06t6jQq84vBIiJk1LWn9opyqzSqLqK0On/Ctw14u7XXVfmQ4MGDVx7hszBQyNoBwAAGU6FoLQeuxrQCt61vNtff/3llj1UZefLLrssxcrPAJAWjKynz778+eef3blbwbfq8ihwf/311900BdUj0fJ7+hoccRcGIg4PQTsAAEgKzWPUiLvW5r3vvvusUqVKyd4kAMARBuxa1UbTDrRsp+oJ3Hzzza7jVRkNCty1fKdG2lVUt3jx4sne9EyJbiYAAJAUmtf+/PPP2zfffGP33HOPff/998neJADAYfABe58+fdxqN1prXUG5X8LzzTffdFMQVFxUQfzSpUttwIAByd7sTIvJHAAAIGlOP/10t/RPz549XaEoAEB4Beefz5o1yz744AN75513rH79+jZlyhS32scZZ5zhlnJT2nvr1q3tqquuctX5mzRpkuzNz7RIjwcAAEm3Y8cOVykeABD+lPitW7fa33//bUOGDHGrgKgi/PXXX+9S5bUme4sWLdxa7ZrTrpVvPOawpw5BOwAAAADgsAL2wYMHu4C8d+/ebvUPdbhqNL1y5couBV4j8bq/ZMkStxKIRuCFCvGpx5x2AAAAAMAB+YC9V69e9vjjj9u5557rAnkF7FpSTyuCqDq8AvMtW7a41yqAV8CuxwjY04Y57QAAAACAg5o+fbpNmDAhOofdK1y4sFu284UXXnBTnTSvXV+bNWvmgnWW2Us7gnYAAAAAwEGtXr3a8ufPb6eeeup+hek0n13Pffjhh1axYkUbP368m7tOwJ4YBO0AAAAAgBT5wFyF51RILvi4f279+vXWtm1blxKvIF2PaZ12LfuGtKPbAwAAAACQIj8fvVGjRrZs2TJXMd4/rgBdc9i1Rvvs2bPd6LoeVzBPwJ44VI8HAAAAAByS5q3feuutdvPNN9ull15qefLksccee8yNtC9cuJBAPZ0QtAMAAAAADkmh43vvvWe33XabS5UvWrSoHXvssTZ58mQ76qijWIc9nRC0AwAAAAAO23/+8x+31JsKzZ1wwgkuTZ457OmHoB0AAAAAkGpUiU9fBO0AAAAAAIQU3SEAAAAAAIQUQTsAAAAAACFF0A4AAAAAQEgRtAMAAAAAEFIE7QAAAAAAhBRBOwAAAAAAIUXQDgAAAABASBG0AwAAAAAQUgTtAABkAh06dLAcOXK421FHHWWlS5e2Cy64wEaNGmX79u1L2nb9/PPPbptKlSplW7ZsiXnutNNOs4ceeihp2wYAQFZA0A4AQCZx0UUX2bp161yg/NFHH1mjRo3s9ttvt0svvdT27NlzwO/bvXt3um+bAvYnnngi3X8PAADZDUE7AACZRN68ea1MmTJ27LHH2hlnnGH33nuvvfvuuy6AHzNmTPR1Gvl+7rnn7LLLLrMCBQrYo48+6p4vWrRozM+bNGmSe23QI4884kbNCxUqZP/85z/tnnvucSPmh9KtWzd78sknbePGjQd8zSuvvGJ16tRxP1t/R5s2bWJe/+mnn7rt+de//mWnn3665cuXz84//3z3Gv2Np5xyihUuXNh93/bt26Pfp0yD/v37W+XKld331KpVy956663D3q8AAIQZQTsAAJmYgloFqRMnTox5XGnpLVu2tG+//dY6dux4WD9r3LhxLsB//PHHbeHChVahQgUX/B+Oa6+91k488UTr16/fQUf8H374Yfvmm29ch4EyBpT2H0/b/uyzz9qcOXPsl19+sauuusqGDBli48ePtw8++MA+/vhje+aZZ6KvV8A+duxYGzFihC1ZssS6d+9u1113nc2cOfOwth0AgDDLnewNAAAAaXPyySfb4sWLYx7TaPQNN9xwRD9HgXCnTp2i39enTx8XIG/duvWQ36sR8gEDBljz5s1d0HzCCSfs95pg58Hxxx9vQ4cOtTPPPNP9/IIFC8aM9tevX9/9X9vTu3dvW7FihfseueKKK+yTTz6xXr162c6dO+2xxx6zadOmWb169aI/+7PPPrPnn3/ezjvvvCPaBwAAhA0j7QAAZHKRSGS/NHeloR+ppUuX2llnnRXzWPz9g2natKk1aNDAHnjggRSf1+i9gnqN4CtF3gfUq1evjnldzZo1o/9Xwb38+fNHA3b/mE+rX758uUuVV1E+Bf7+ppF3BfoAAGR2jLQDAJDJff/9924+d5DmsgflzJnTBffpXaBOo+0a8e7Zs2fM49u2bXNBvW5Kwy9ZsqQL1nV/165dMa9VdXzPV8sP0mO+Yr7PAlDavOb6x9cAAAAgsyNoBwAgE5sxY4abt66U9INRkKwK7wqefUC/aNGimNecdNJJ9uWXX1q7du2ij+n+kdDIfKtWrVwBu6AffvjBfv/9dxfUly9f3j22YMECS6tq1aq54FwdAKTCAwCyIoJ2AAAyCc3fXr9+ve3du9c2bNhgU6ZMcUXYtORbMNBOSd26dV2auSrO33bbbTZ//vyYivO+Anznzp1dav3ZZ59tb7zxhpsrH0xNPxwqZnfqqada7tz/38xQSnyePHncvPkuXbrYd99954rSpZXS7O+66y7XaaHRd6Xnb9q0yT7//HNXab59+/Zp/h0AACQTc9oBAMgkFKSXLVvWKlWq5NZsVzE2FXPTsm+5cuU66PcWK1bMXn31Vfvwww+tRo0a9tprr7kq7UFt27Z1Rd8UBGtJuZUrV7rq7kcfffQRbWfVqlVd0bkdO3bEjPSrk2DChAludFwj7ola113Bv+bRqwNDy8Jp3yhdPn7KAAAAmVGOSPwENwAAgP9RgTetqa411gEAQMYjPR4AADiqwq61zlUcTiP3Go3XUmpTp05N9qYBAJBtMdIOAACcv//+2y3J9vXXX7vUdhWmu//++11hOQAAkBwE7QAAAAAAhBSF6AAAAAAACCmCdgAAAAAAQoqgHQAAAACAkCJoBwAAAAAgpAjaAQAAAAAIKYJ2AAAAAABCiqAdAAAAAICQImgHAAAAAMDC6f8ASPDSM9Xs0vAAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 1200x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(12,5))\n",
    "sns.barplot(x=merged_df['Drug Name'].value_counts().head(10).index, \n",
    "            y=merged_df['Drug Name'].value_counts().head(10).values)\n",
    "plt.xticks(rotation=45)\n",
    "plt.xlabel(\"Drug Name\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.title(\"Top 10 Most Mentioned Drugs in DDICorpus\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>entity_1</th>\n",
       "      <th>entity_2</th>\n",
       "      <th>sentence</th>\n",
       "      <th>Drug Name_1</th>\n",
       "      <th>Description_1</th>\n",
       "      <th>Description Length_1</th>\n",
       "      <th>Drug Name_2</th>\n",
       "      <th>Description_2</th>\n",
       "      <th>Description Length_2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>heparin</td>\n",
       "      <td>warfarin</td>\n",
       "      <td>These medications have included heparin, warfa...</td>\n",
       "      <td>heparin</td>\n",
       "      <td>Unfractionated heparin (UH) is a heterogenous ...</td>\n",
       "      <td>138.0</td>\n",
       "      <td>warfarin</td>\n",
       "      <td>Warfarin is an anticoagulant drug normally use...</td>\n",
       "      <td>125.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>disulfiram</td>\n",
       "      <td>diazepam</td>\n",
       "      <td>Pharmacokinetic studies indicate that administ...</td>\n",
       "      <td>disulfiram</td>\n",
       "      <td>A carbamate derivative used as an alcohol dete...</td>\n",
       "      <td>58.0</td>\n",
       "      <td>diazepam</td>\n",
       "      <td>A benzodiazepine with anticonvulsant, anxiolyt...</td>\n",
       "      <td>173.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>digoxin</td>\n",
       "      <td>hydrochlorothiazide</td>\n",
       "      <td>No significant interactions with digoxin, hydr...</td>\n",
       "      <td>digoxin</td>\n",
       "      <td>Digoxin is one of the oldest cardiovascular me...</td>\n",
       "      <td>106.0</td>\n",
       "      <td>hydrochlorothiazide</td>\n",
       "      <td>Hydrochlorothiazide is the most commonly presc...</td>\n",
       "      <td>55.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>probenecid</td>\n",
       "      <td>acyclovir</td>\n",
       "      <td>Co-administration of probenecid with acyclovir...</td>\n",
       "      <td>probenecid</td>\n",
       "      <td>The prototypical uricosuric agent. It inhibits...</td>\n",
       "      <td>49.0</td>\n",
       "      <td>acyclovir</td>\n",
       "      <td>Acyclovir is a deoxynucleoside analog antivira...</td>\n",
       "      <td>55.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>glibenclamide</td>\n",
       "      <td>acitretin</td>\n",
       "      <td>Repeating the study with 6 healthy male volunt...</td>\n",
       "      <td>glibenclamide</td>\n",
       "      <td>Glyburide is a second generation sulfonylurea ...</td>\n",
       "      <td>75.0</td>\n",
       "      <td>acitretin</td>\n",
       "      <td>An oral retinoid effective in the treatment of...</td>\n",
       "      <td>28.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3773</th>\n",
       "      <td>cocaine</td>\n",
       "      <td>desipramine</td>\n",
       "      <td>This defect in the failing heart can be mimick...</td>\n",
       "      <td>cocaine</td>\n",
       "      <td>An alkaloid ester extracted from the leaves of...</td>\n",
       "      <td>76.0</td>\n",
       "      <td>desipramine</td>\n",
       "      <td>Desipramine hydrochloride is a dibenzazepine-d...</td>\n",
       "      <td>197.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3774</th>\n",
       "      <td>norepinephrine</td>\n",
       "      <td>cocaine</td>\n",
       "      <td>Compromised norepinephrine uptake-1 in functio...</td>\n",
       "      <td>norepinephrine</td>\n",
       "      <td>Precursor of epinephrine that is secreted by t...</td>\n",
       "      <td>55.0</td>\n",
       "      <td>cocaine</td>\n",
       "      <td>An alkaloid ester extracted from the leaves of...</td>\n",
       "      <td>76.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3776</th>\n",
       "      <td>pentagastrin</td>\n",
       "      <td>histamine</td>\n",
       "      <td>It was established that both angiotensins inhi...</td>\n",
       "      <td>pentagastrin</td>\n",
       "      <td>A synthetic pentapeptide that mimics the actio...</td>\n",
       "      <td>35.0</td>\n",
       "      <td>histamine</td>\n",
       "      <td>A depressor amine derived by enzymatic decarbo...</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3785</th>\n",
       "      <td>temazepam</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>Acid-catalyzed ethanolysis of temazepam in anh...</td>\n",
       "      <td>temazepam</td>\n",
       "      <td>Temazepam, like many other similar and related...</td>\n",
       "      <td>181.0</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>A clear, colorless liquid rapidly absorbed fro...</td>\n",
       "      <td>50.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3787</th>\n",
       "      <td>temazepam</td>\n",
       "      <td>benzodiazepine</td>\n",
       "      <td>In addition to this pharmacological interactio...</td>\n",
       "      <td>temazepam</td>\n",
       "      <td>Temazepam, like many other similar and related...</td>\n",
       "      <td>181.0</td>\n",
       "      <td>benzodiazepine</td>\n",
       "      <td>Benzodiazepine is under investigation for the ...</td>\n",
       "      <td>33.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>895 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            entity_1             entity_2  \\\n",
       "6            heparin             warfarin   \n",
       "10        disulfiram             diazepam   \n",
       "29           digoxin  hydrochlorothiazide   \n",
       "41        probenecid            acyclovir   \n",
       "44     glibenclamide            acitretin   \n",
       "...              ...                  ...   \n",
       "3773         cocaine          desipramine   \n",
       "3774  norepinephrine              cocaine   \n",
       "3776    pentagastrin            histamine   \n",
       "3785       temazepam              ethanol   \n",
       "3787       temazepam       benzodiazepine   \n",
       "\n",
       "                                               sentence     Drug Name_1  \\\n",
       "6     These medications have included heparin, warfa...         heparin   \n",
       "10    Pharmacokinetic studies indicate that administ...      disulfiram   \n",
       "29    No significant interactions with digoxin, hydr...         digoxin   \n",
       "41    Co-administration of probenecid with acyclovir...      probenecid   \n",
       "44    Repeating the study with 6 healthy male volunt...   glibenclamide   \n",
       "...                                                 ...             ...   \n",
       "3773  This defect in the failing heart can be mimick...         cocaine   \n",
       "3774  Compromised norepinephrine uptake-1 in functio...  norepinephrine   \n",
       "3776  It was established that both angiotensins inhi...    pentagastrin   \n",
       "3785  Acid-catalyzed ethanolysis of temazepam in anh...       temazepam   \n",
       "3787  In addition to this pharmacological interactio...       temazepam   \n",
       "\n",
       "                                          Description_1  Description Length_1  \\\n",
       "6     Unfractionated heparin (UH) is a heterogenous ...                 138.0   \n",
       "10    A carbamate derivative used as an alcohol dete...                  58.0   \n",
       "29    Digoxin is one of the oldest cardiovascular me...                 106.0   \n",
       "41    The prototypical uricosuric agent. It inhibits...                  49.0   \n",
       "44    Glyburide is a second generation sulfonylurea ...                  75.0   \n",
       "...                                                 ...                   ...   \n",
       "3773  An alkaloid ester extracted from the leaves of...                  76.0   \n",
       "3774  Precursor of epinephrine that is secreted by t...                  55.0   \n",
       "3776  A synthetic pentapeptide that mimics the actio...                  35.0   \n",
       "3785  Temazepam, like many other similar and related...                 181.0   \n",
       "3787  Temazepam, like many other similar and related...                 181.0   \n",
       "\n",
       "              Drug Name_2                                      Description_2  \\\n",
       "6                warfarin  Warfarin is an anticoagulant drug normally use...   \n",
       "10               diazepam  A benzodiazepine with anticonvulsant, anxiolyt...   \n",
       "29    hydrochlorothiazide  Hydrochlorothiazide is the most commonly presc...   \n",
       "41              acyclovir  Acyclovir is a deoxynucleoside analog antivira...   \n",
       "44              acitretin  An oral retinoid effective in the treatment of...   \n",
       "...                   ...                                                ...   \n",
       "3773          desipramine  Desipramine hydrochloride is a dibenzazepine-d...   \n",
       "3774              cocaine  An alkaloid ester extracted from the leaves of...   \n",
       "3776            histamine  A depressor amine derived by enzymatic decarbo...   \n",
       "3785              ethanol  A clear, colorless liquid rapidly absorbed fro...   \n",
       "3787       benzodiazepine  Benzodiazepine is under investigation for the ...   \n",
       "\n",
       "      Description Length_2  \n",
       "6                    125.0  \n",
       "10                   173.0  \n",
       "29                    55.0  \n",
       "41                    55.0  \n",
       "44                    28.0  \n",
       "...                    ...  \n",
       "3773                 197.0  \n",
       "3774                  76.0  \n",
       "3776                  31.0  \n",
       "3785                  50.0  \n",
       "3787                  33.0  \n",
       "\n",
       "[895 rows x 9 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Extract drug pairs from sentences\n",
    "ddi_pairs = df_train.dropna(subset=['entity_1', 'entity_2'])[['entity_1', 'entity_2', 'sentence']]\n",
    "\n",
    "# Check if both drugs exist in DrugBank\n",
    "ddi_pairs_matched = ddi_pairs.merge(drugbank_df, left_on='entity_1', right_on='Drug Name', how='left')\\\n",
    "                             .merge(drugbank_df, left_on='entity_2', right_on='Drug Name', suffixes=('_1', '_2'), how='left')\n",
    "\n",
    "# Display pairs where both drugs exist in DrugBank\n",
    "ddi_pairs_matched.dropna(subset=['Description_1', 'Description_2'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
